Sentence,class,file
"http://dx.doi.org/10.1083/jcb.120.6.129 3 Herbert, J.M., J.M.",Non-OADS,/arxiv_data1/oa_pdf/d6/16/JCB_201406004.PMC4137061.pdf
"http://dx.doi.org/10   .1016/0092-8674(90)90471- P Porwal, M., S. Cohen, K. Snoussi, R. Popa-Wagner, F. Anderson, N. Dugot- Senant, H. Wodrich, C. Dinsart, J.A.",Non-OADS,/arxiv_data1/oa_pdf/d6/16/JCB_201406004.PMC4137061.pdf
"http://dx.doi   .org/10.1371/journal.ppat.100367 1 Ron, D., and M.G.",Non-OADS,/arxiv_data1/oa_pdf/d6/16/JCB_201406004.PMC4137061.pdf
"http://dx.doi.org/10   .1007/s00412-013-0399- 8 Sims, J.R., S. Karp, and D.E.",OADS,/arxiv_data1/oa_pdf/d6/16/JCB_201406004.PMC4137061.pdf
"http://dx.doi.org/10.1074/jbc.M30201620 0 Speese, S.D., J. Ashley, V. Jokhi, J. Nunnari, R. Barria, Y. Li, B. Ataman, A.  Koon, Y.T.",Non-OADS,/arxiv_data1/oa_pdf/d6/16/JCB_201406004.PMC4137061.pdf
"http://dx.doi.org/10.1016/j.cell.2012.03.03 2 Sullivan, T., D. Escalante-Alcalde, H. Bhatt, M. Anver, N. Bhat, K. Nagashima,  C.L.",OADS,/arxiv_data1/oa_pdf/d6/16/JCB_201406004.PMC4137061.pdf
"http://dx.doi.org/10.1083/jcb.147.5.91 3 Toker, A.",Non-OADS,/arxiv_data1/oa_pdf/d6/16/JCB_201406004.PMC4137061.pdf
"122:1477– 1486. http://dx.doi.org/10.1242/jcs.03733 3 Yanai, I., L. Peshkin, P. Jorgensen, and M.W.",Non-OADS,/arxiv_data1/oa_pdf/d6/16/JCB_201406004.PMC4137061.pdf
"http://dx.doi.org/10.1016/j   .devcel.2011.03.01 5 Zink, D., A.H. Fischer, and J.A.",OADS,/arxiv_data1/oa_pdf/d6/16/JCB_201406004.PMC4137061.pdf
http://dx.doi.org/10.1038/nrc143 0,Non-OADS,/arxiv_data1/oa_pdf/d6/16/JCB_201406004.PMC4137061.pdf
"Recent work on tubulin PTMs has shed light on how  these modifications could contribute to a “tubulin code”  that coordinates the complex functions of microtubules   in cells.The tubulin code: Molecular components,   readout mechanisms, and functions Carsten Janke1,2,3,4 1Institut Curie, 91405 Orsay, France 2Centre National de la Recherche Scientifique Unité Mixte de Recherche 3306, 91405 Orsay, France 3Institut National de la Santé et de la Recherche Médicale U1005, 91405 Orsay, France 4Paris Sciences et Lettres Research University, 75005 Paris, France © 2014 Janke  This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1091/mbc.E13-10-060 9 Aiken, J., D. Sept, M. Costanzo, C. Boone, J.A.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1016/j.cub.2014.03.07 8 Akella, J.S., D. Wloga, J. Kim, N.G.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1038/nature0932 4 Alexander, J.E., D.F.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10   .1016/0014-5793(83)81119- 3 Arce, C.A., J.A.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
http://dx.doi.org/   10.1111/j.1432-1033.1975.tb02435.,Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
http://dx.doi.org/10.1111/j.1471-4159.1980   .tb04628.,Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1091/mbc.4.6.61 5 Audebert, S., A. Koulakoff, Y .",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/j.ceb.2013.02.01 8 Berezniuk, I., H.T.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1074/jbc.M111.30913 8 Berezniuk, I., P.J.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"288:30445– 30453. http://dx.doi.org/10.1074/jbc.M113.49791 7 Bieling, P., S. Kandels-Lewis, I.A.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1083/jcb.20080919 0 Bobinnec, Y ., A. Khodjakov, L.M.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10   .1007/978-1-61779-252-6_ 3 Eddé, B., J. Rossier, J.P.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1126/science.196719 4 Eipper, B.A.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1083/jcb.120.3.72 5 Fallet-Bianco, C., L. Loeuillet, K. Poirier, P. Loget, F. Chapon, L. Pasquier, Y .",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1093/brain/   awn15 5 Farrell, K.W.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/0076-6879(82)   85039- 8 Faruki, S., R.L.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1126/science.106891 2 Fouquet, J.P., B. Eddé, M.L.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/   j.pep.2005.05.01 1 Fourest-Lieuvin, A., L. Peris, V .",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1091/mbc.E05-07-062 1 Gaertig, J., T.H.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10   .1083/jcb.100.3.76 4 Geuens, G., G.G.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1083/jcb.103.5.188 3 Greer, C.A., and G.M.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/0006-   8993(82)90206- 2 Gundersen, G.G., and J.C. Bulinski.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10   .1016/0092-8674(84)90273- 3 Gundersen, G.G., S. Khawaja, and J.C. Bulinski.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1083/jcb.105.1.25 1 Hallak, M.E., J.A.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1016/0014-5793(77)80968- XBosch Grau, M., G. Gonzalez Curto, C. Rocha, M.M.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1083/jcb.20130504 1 Bré, M.H., V. Redeker, M. Quibell, J. Darmanaden-Delorme, C. Bressac, J.  Cosson, P. Huitorel, J.M.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10   .1073/pnas.76.1.29 3 Cambray-Deakin, M.A., and R.D.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1002/cm.97008030 9 Cambray-Deakin, M.A., and R.D.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1083/   jcb.104.6.156 9 Caron, J.M.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1091/mbc.8.4.62 1 Caron, J.M., L.R.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/S1046-   5928(03)00218- 3 Caudron, F., E. Denarier, J.-C. Thibout-Quintana, J. Brocard, A. Andrieux, and  A. Fourest-Lieuvin.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1371/journal.pone.001355 3 Cederquist, G.Y., A. Luchniak, M.A.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1093/hmg/dds39 3 Choudhary, C., C. Kumar, F. Gnad, M.L.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1091/ mbc.E10-03-020 3 Cleveland, D.W., M.W.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1016/0092-8674(78)90286- 6 Deanin, G.G., and M.W.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/0006-291X(76)90841- X Denoulet, P., B. Eddé, and F. Gros.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/0378-1119(86)90333- 1 Díaz-Nido, J., L. Serrano, C. López-Otín, J. Vandekerckhove, and J. Avila.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
http://dx.doi.org/   10.1523/JNEUROSCI.0037-07.200 7,Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1007/   978-1-61779-252-6_ 4 Lacroix, B., J. van Dijk, N.D. Gold, J. Guizetti, G. Aldrian-Herrada, K. Rogowski,  D.W. Gerlich, and C. Janke.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1083/jcb.101.3.85 2 Lewis, S.A., W. Gu, and N.J. Cowan.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/0092-8674(87)90456- 9 L’Hernault, S.W., and J.L.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1021/   bi00323a03 4 Liao, G., and G.G.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1074/jbc.273.16.979 7 Linck, R., X. Fu, J. Lin, C. Ouch, A. Schefter, W. Steffen, P. Warren, and D.  Nicastro.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1074/jbc.M114.56894 9 Ludueña, R.F., and A. Banerjee.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10   .1073/pnas.081239110 6 Magiera, M.M., and C. Janke.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/B978-0-12-407757-7.00016- 5 Marcos, S., J. Moreau, S. Backer, D. Job, A. Andrieux, and E. Bloch-Gallego.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi   .org/10.1371/journal.pone.000540 5 Mary, J., V .",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/0014-5793(94)01018- 8 Mary, J., V. Redeker, J.P.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1074/jbc.271.17.992 8 Mary, J., V. Redeker, J.P.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1023/A:102633672212 4 Mialhe, A., L. Lafanechère, I. Treilleux, N. Peloux, C. Dumontet, A. Brémond,  M.H.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1038/nature1257 1Honnappa, S., O. Okhrimenko, R. Jaussi, H. Jawhari, I. Jelesarov, F.K.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/j.molcel.2006.07.01 3 Howes, S.C., G.M.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10   .1091/mbc.E13-07-038 7 Huang, K., D.R.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1083/jcb.20090306 6 Hubbert, C., A. Guardiola, R. Shao, Y .",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1038/417455 a Ikegami, K., M. Mukai, J. Tsuchida, R.L.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1074/jbc.M60398420 0 Ikegami, K., S. Sato, K. Nakamura, L.E.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1126/science.111301 0 Jenuwein, T., and C.D.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1126/science.106312 7 Ji, S., J.G.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1021/bi200517 4 Joshi, H.C., and D.W. Cleveland.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1083/jcb.109.2.66 3 Kalebic, N., S. Sorrentino, E. Perlas, G. Bolasco, C. Martinez, and P.A.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"4:1962. http://dx.doi.org/10.1038/ncomms296 2 Kalinina, E., R. Biswas, I. Berezniuk, A. Hermoso, F.X.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1096/fj.06-7329co m Kann, M.L., Y. Prigent, N. Levilliers, M.H.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi   .org/10.1002/(SICI)1097-0169(1998)41:4<341::AID-CM6>3.0.CO;2- 8 Katsuki, M., D.R.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1074/jbc.C109.05215 9 Kaul, N., V .",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/j.bpj.2014.05.00 8 Keays, D.A., G. Tian, K. Poirier, G.-J.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/j.cell.2006.12.01 7 Khawaja, S., G.G.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10   .1083/jcb.106.1.14 1 Kimura, Y ., N. Kurabe, K. Ikegami, K. Tsutsumi, Y .",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1074/jbc.C110.12828 0 Konishi, Y ., and M. Setou.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10   .1038/nn.231 4 Kreitzer, G., G. Liao, and G.G.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1091/mbc.10.4.110 5 Kubo, T., H.A.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
http://dx.doi.org/10   .1016/j.cub.2009.12.05 8,OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/j.cub.2006.09.01 4 Regnard, C., E. Desbruyères, J.C. Huet, C. Beauvallet, J.C. Pernollet, and B.  Eddé.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1074/jbc.M00004520 0 Regnard, C., D. Fesquet, C. Janke, D. Boucher, E. Desbruyéres, A. Koulakoff, C.  Insina, P. Travo, and B. Eddé.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1242/jcs.0074 3 Ren, Y ., J. Zhao, and J. Feng.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1002/cm.97025010 4 Robson, S.J., and R.D.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1002/cm.97012040 8 Rodriguez de la Vega, M., R.G.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1096/fj.06-7330co m Rogowski, K., F. Juge, J. van Dijk, D. Wloga, J.-M. Strub, N. Levilliers, D.  Thomas, M.H.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/j.cell   .2009.05.02 0 Rogowski, K., J. van Dijk, M.M.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/j.cell.2010.10.01 4 Rosas-Acosta, G., W.K.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1074/   mcp.M400149-MCP20 0 Rüdiger, M., U. Plessman, K.D.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1016/0014-5793(92)81061- P Rusconi, F., M.C.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10   .1021/bi970752 e Schröder, H.C., J. Wehland, and K. Weber.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1083/jcb.100.1.27 6 Schwer, H.D., P. Lecine, S. Tiwari, J.E.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)00153- 1 Sherwin, T., A. Schneider, R. Sasse, T. Seebeck, and K. Gull.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1083/jcb.104.3.43 9 Shida, T., J.G.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1038/ncb292 0 Song, Y ., L.L.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/j.neuron.2013   .01.03 6 Soppina, V ., J.F.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1371/journal   .pone.004820 4 Sulimenko, V ., E. Dráberová, T. Sulimenko, L. Macurek, V .",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.4049/jimmunol.176.12.724 3 Suryavanshi, S., B. Eddé, L.A. Fox, S. Guerrero, R. Hard, T. Hennessey, A. Kabi,  D. Malison, D. Pennock, W.S.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1021/bi802047 y Mullen, R.J., E.M. Eicher, and R.L.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10   .1074/jbc.M20713420 0 Nicastro, D., X. Fu, T. Heuser, A. Tso, M.E.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1073/pnas.110617810 8 Niwa, S., H. Takahashi, and N. Hirokawa.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1038/emboj.2013.5 9 Nogales, E., S.G. Wolf, and K.H.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/S1097-2765(03)00038- 8 Ozols, J., and J.M.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1091/mbc.8.4.63 7 Pathak, N., T. Obara, S. Mangos, Y .",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1091/mbc   .E07-06-053 7 Pathak, N., C.A.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1074/jbc.M110.20981 7 Paturle, L., J. Wehland, R.L.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1021/bi00107a02 2 Paturle-Lafanechère, L., M. Manier, N. Trigault, F. Pirollet, H. Mazarguil, and  D. Job.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10   .1083/jcb.20051205 8 Peris, L., M. Wagenbach, L. Lafanechère, J. Brocard, A.T. Moore, F. Kozielski,  D. Job, L. Wordeman, and A. Andrieux.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"185:1159– 1166. http://dx.doi.org/10.1083/jcb.20090214 2 Peters, J.D., M.T.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1074/jbc.271.9.475 5 Prota, A.E., M.M.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1083/jcb.20121101 7 Raff, E.C., H.D.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/j.cub.2008.05.03 1 Raybin, D., and M. Flavin.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"65:1088– 1095. http://dx.doi.org/10.1016/S0006-291X(75)80497- 9 Redeker, V ., J.P.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1091/mbc.E12-06-044 4 Wloga, D., D.M.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/j.devcel.2009.04.00 8 Wolff, A., B. de Néchaud, D. Chillet, H. Mazarguil, E. Desbruyères, S. Audebert,  B. Eddé, F. Gros, and P. Denoulet.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1371/journal.pbio   .005025 8 Xia, L., B. Hai, Y .",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1083/jcb.149.5.109 7 Xiao, H., K. El Bissati, P. Verdier-Pinard, B. Burd, H. Zhang, K. Kim, A.  Fiser, R.H. Angeletti, and L.M.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1021/pr900699 a Xie, R., K.M.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1128/EC   .00366-0 6 Xu, G., J.S.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1038/nbt.165 4 Yaffe, M.B., B.S.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1021/bi00406a01 2 Yaffe, M.B., G.W.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1038/358245a 0 Zyss, D., P. Montcourrier, B. Vidal, C. Anguille, F. Mérezègue, A. Sahuquet, P.H.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-05-127 0regulates ciliary motility by altering inner dynein arm activity.,Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/j.cub.2009.12.06 2 Szyk, A., A.M. Deaconescu, G. Piszczek, and A. Roll-Mecak.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1038/nsmb.214 8 Szyk, A., G. Piszczek, and A. Roll-Mecak.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"425:2412– 2414. http://dx.doi.org/10.1016/j.jmb.2013.04.01 7 Szyk, A., A.M. Deaconescu, J. Spector, B. Goodman, M.L.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/j.cell   .2014.03.06 1 Tian, G., Y .",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80100- 2 Tischfield, M.A., H.N.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/   j.cell.2009.12.01 1 Tischfield, M.A., G.Y .",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"21:286– 294. http://dx.doi.org/10.1016/j.gde.2011.01.00 3 Vainberg, I.E., S.A. Lewis, H. Rommelaere, C. Ampe, J. Vandekerckhove, H.L.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1016/S0092-8674(00)81446- 4 Valenzuela, P., M. Quiroga, J. Zaldivar, W.J.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1016/j.tcb.2008.04.00 3 Vallee, R.B.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/0076-6879(86)34078- 3 van Dijk, J., K. Rogowski, J. Miro, B. Lacroix, B. Eddé, and C. Janke.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/j.molcel.2007.04.01 2 van Dijk, J., J. Miro, J.-M. Strub, B. Lacroix, A. van Dorsselaer, B. Eddé, and C.  Janke.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1074/jbc.M70581320 0 Vemu, A., C.P.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1016/B978-0-12-   397924-7.00009- 1 Verhey, K.J., and J. Gaertig.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.4161/cc.6.17.463 3 V ogel, P., G. Hansen, G. Fontenot, and R. Read.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi   .org/10.1177/030098581036348 5 Walgren, J.L.E., T.S.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1371/journal.pone.004221 8 Wang, D., A. Villasante, S.A. Lewis, and N.J. Cowan.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/   10.1083/jcb.103.5.190 3 Weatherbee, J.A., R.B.",OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"http://dx.doi.org/10.1038/ncb293 8 Widlund, P.O., M. Podolski, S. Reber, J. Alper, M. Storch, A.A. Hyman, J. Howard,  and D.N.",Non-OADS,/arxiv_data1/oa_pdf/e5/62/JCB_201406055.PMC4137062.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6123 | DOI: 10.1038/srep06123 4",Non-OADS,/arxiv_data1/oa_pdf/e4/fd/srep06123.PMC4137260.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/12/50/srep06125.PMC4137261.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fc/92/srep06124.PMC4137265.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6124 | DOI: 10.1038/srep06124 5",Non-OADS,/arxiv_data1/oa_pdf/fc/92/srep06124.PMC4137265.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/27/35/srep06122.PMC4137339.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/98/41/srep06115.PMC4137340.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6115 | DOI: 10.1038/srep06115 5",Non-OADS,/arxiv_data1/oa_pdf/98/41/srep06115.PMC4137340.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/db/b8/srep06127.PMC4137342.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6127 | DOI: 10.1038/srep06127 10",Non-OADS,/arxiv_data1/oa_pdf/db/b8/srep06127.PMC4137342.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5a/7c/srep06120.PMC4137343.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6120 | DOI: 10.1038/srep06120 7",Non-OADS,/arxiv_data1/oa_pdf/5a/7c/srep06120.PMC4137343.pdf
"conceived and led theproject, interpreted the data and revised the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.",Non-OADS,/arxiv_data1/oa_pdf/9c/a3/srep06116.PMC4137344.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6116 | DOI: 10.1038/srep06116 12",Non-OADS,/arxiv_data1/oa_pdf/9c/a3/srep06116.PMC4137344.pdf
"However, theFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Mov Disord 2010;25:534–541, doi: http://dx.doi.org/10.1002/mds.22838.",OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Neurology 2005;64:1721–1725, doi: http://dx.doi.org/10.1212/01.WNL.0000161852.70374.01.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"J Neurol Neurosurg Psychiatry 1984;47: 466–470, doi: http://dx.doi.org/10.1136/jnnp.47.5.466.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Neurology 2007;69:1982–1989, doi: http://dx.doi.org/10.1212/01.wnl.0000279339.87987.d7.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Neurology 2003;61: 1804–1806, doi: http://dx.doi.org/10.1212/01.WNL.0000099075.19951.8C.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Mov Disord 2003;18:389–394, doi: http://dx.doi.org/10.1002/mds.10376.",OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Gerontologist 1995;35:556–559, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Louis ED, Ottman R Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Acta Neurologica Belgica 2013;113:127–131, doi: http://dx.doi.org/10.1007/s13760-012-0147-5.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
Tremor Other Hyperkinet Mov 2012;2:http://tremorjournal.org/article/ view/81.,Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"BMC Neurol 2012;12:110, doi: http://dx.doi.org/10.1186/1471-2377-12- 110.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Neuroepidemiology 2011;36:71– 76, doi: http://dx.doi.org/10.1159/000323389.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
Tremor Other Hyperkinet Mov 2013;3:http://tremorjournal.org/article/view/192.,Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Internet release data: December 2013.http://www.census.gov/population/age/data/2012comp.html 16.Hornabrook RW, Nagurney JT.",OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Brain 1976;99:659–672, doi: http://dx.doi.org/10.1093/brain/99.4.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Neurology 1994;44:61–64, doi: http://dx.doi.org/10.1212/WNL.44.1.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Mov Disord 2009; 24:119–122, doi: http://dx.doi.org/10.1002/mds.22324.",OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Mov Disord 2007;22:540–545, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Parkinsonism Relat Disord 2009;15:101–104, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Arch Neurol 1995;52:1201–1205, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Prevalence of essential tremor in a multiethnic, community-based study in northern Manhattan, New York, N.Y. Neuroepidemiology 2009;32:208–214, doi: http://dx.doi.org/10.1159/000195691.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Neuroepidemiology 2001;20:125–128, doi: http://dx.doi.org/10.1159/000054771.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Neuroepidemiology 1994;13:175–178, doi: http://dx.doi.org/10.1159/000110376.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Parkinsonism Relat Disord 1996;2:205–208, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Brain 1994;117(Pt 4):805–824, doi: http://dx.doi.org/10.1093/brain/ 117.4.805.",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"J Neurol 2005;252:570–574, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
"Mov Disord 1998;13:803– 808, doi: http://dx.doi.org/10.1002/mds.870130508.Louis ED, Ottman R How Many People Have Essential Tremor?",Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/24/89/tre-04-259-5701-1.PMC4137360.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/fc/0a/ncomms5521.PMC4137407.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wisedchaisri, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/fc/0a/ncomms5521.PMC4137407.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5521 ARTICLE NATURE COMMUNICATIONS | 5:4521 | DOI: 10.1038/ncomms5521 | www.nature.com/naturecommunications 11 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/fc/0a/ncomms5521.PMC4137407.pdf
Available from: http://en.wikipedia.org/wiki/List_of_Asian_ countries_by_population.,Non-OADS,/arxiv_data1/oa_pdf/4a/80/IJOrtho-48-410.PMC4137521.pdf
This an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/83/nihms-619583.PMC4137565.pdf
A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf  .,OADS,/arxiv_data1/oa_pdf/71/83/nihms-619583.PMC4137565.pdf
Available from: http://www.bcm.edu/gastro/DDC/grandrounds/ BCM/12‑18‑03/D‑LAYOUT .HTM.,Non-OADS,/arxiv_data1/oa_pdf/a8/23/IJABMR-4-119.PMC4137636.pdf
Available  from: http://www.biospectrumasia.com/biospectrum/analysis/3021/ biosimilars‑guidelines‑a‑step‑direction‑india#.UehBf6DRiSo.,Non-OADS,/arxiv_data1/oa_pdf/76/9e/IJABMR-4-63.PMC4137643.pdf
Available from: http://www.thehindubusinessline.,Non-OADS,/arxiv_data1/oa_pdf/76/9e/IJABMR-4-63.PMC4137643.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/Press_release/2009/11/WC500015335.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/9e/IJABMR-4-63.PMC4137643.pdf
Available from: http://www.ema.Europa.eu/human/ biosimilar/0437004en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/9e/IJABMR-4-63.PMC4137643.pdf
Available from:  http://www.ema.europa.eu/odfs/human/biosimilar/4283205en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/9e/IJABMR-4-63.PMC4137643.pdf
Available  from: http://www.ema.europa.eu/pdfs/human/biosimilar/043704en.,Non-OADS,/arxiv_data1/oa_pdf/76/9e/IJABMR-4-63.PMC4137643.pdf
Available from: http://www.who.int/ biologicals/areas/biological_therapeutics/BIOTHERAPEUTICS_FOR_ WEB_22 APRIL2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/76/9e/IJABMR-4-63.PMC4137643.pdf
Available from: http://www.gabionline.,Non-OADS,/arxiv_data1/oa_pdf/76/9e/IJABMR-4-63.PMC4137643.pdf
Available from: http://www.who.int/healthinfo/global_burden_disease/ GBD_report_2004update_full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/37/IJABMR-4-67.PMC4137644.pdf
Available from: http://www.en.wikipedia.org/ wiki/Pranayama.,Non-OADS,/arxiv_data1/oa_pdf/4e/37/IJABMR-4-67.PMC4137644.pdf
Available from: http://www.umm.edu/altmed/articles/yoga‑000364.,Non-OADS,/arxiv_data1/oa_pdf/4e/37/IJABMR-4-67.PMC4137644.pdf
Available from: http://www.nlm.nih.gov/medlineplus/ magazine/issues/fall11/articles/fall11pg10‑11.html.,Non-OADS,/arxiv_data1/oa_pdf/4e/37/IJABMR-4-67.PMC4137644.pdf
Available from: http://www.mciindia.org/tools/announcement/MCI_booklet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/da/4b/IJABMR-4-90.PMC4137649.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/5c/msu170.PMC4137704.pdf
"vec- tensis ), databases associated with the Origins of Multicellular- ity Sequencing Project, Broad Institute of Harvard and MIT(http://www.broadinstitute.or g/annotation/genome/multi- cellularity_project/MultiHome.html , last accessed June 6, 2014), and the A. queenslandica genome database (http://www.metazoa.ensembl .org/Amphimedon_queenslan dica/blastview , last accessed June 6, 2014).",OADS,/arxiv_data1/oa_pdf/8b/92/msu178.PMC4137706.pdf
"rosetta FASTA-protein database (Origins of Multicellularity Sequencing Project, Broad Institute of Harvard and MIT; http://www.broadinstitute.org/ ,l a s t accessed June 6, 2014) using Mascot as a search engine in Proteome Discoverer v1.3 (Thermo Scientiﬁc, Bremen, Germany) with a peptide false discovery rate of less than1%, which was estimated on the number of reverse hits.",OADS,/arxiv_data1/oa_pdf/8b/92/msu178.PMC4137706.pdf
"imag.fr/Michael.Blum/ ,http://membres-timc.imag.fr/Nicolas.",Non-OADS,/arxiv_data1/oa_pdf/4e/9c/msu182.PMC4137708.pdf
"Python scripts for the simulations are available at https://github.com/UH-Bioinformatics/hBayeSSC (last accessed June 16, 2014).",OADS,/arxiv_data1/oa_pdf/f9/aa/msu187.PMC4137712.pdf
"List of All Drugs Used in Laboratory Evolution Experiments, Dr ug Abbreviation, Drug Solvent, MIC for the Wild-Type MG1655 Escherichia coli Strain, Commonly Used Clinical Dose (assuming an average body ﬂuid volume of 40 l, daily drug doses are taken from http://www.globalrph.com , last accessed June 25, 2014), Highest MIC Reported in The European Committee on Antim icrobial Susceptibility Testing—EUCAST Database, Mechanism of Action, and Phenotypic Effects.",Non-OADS,/arxiv_data1/oa_pdf/61/a7/msu191.PMC4137714.pdf
Weclassiﬁed such genes as “pathway-speciﬁc genes” and the restof the genes were classiﬁed as “off-pathway genes.” Supplementary Material Supplementary ﬁgures S1–S6 and tables S1–S3 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/61/a7/msu191.PMC4137714.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLES 1174 VOLUME 7 NUMBER 5 |SEPTEMBER 2014 |www.nature.com/mi",Non-OADS,/arxiv_data1/oa_pdf/bc/a8/mi20143a.PMC4137741.pdf
"SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi ACKNOWLEDGMENTS We would like to thank Gerard Hofman (Department of Pharmaceutical Sciences, Utrecht University) for his help with several animal procedures,Debby Smits (Central Animal Laboratory, Radboud University, Nijmegen Medical Centre) for her help in organizing animal experiments and Rob Bleumink (The Center for Cell Imaging, Faculty of Veterinary Medicine,Utrecht University) for his help with the fluorescent imaging.",Non-OADS,/arxiv_data1/oa_pdf/a8/7c/mi201416a.PMC4137742.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLES 1138 VOLUME 7 NUMBER 5 |SEPTEMBER 2014 |www.nature.com/mi",Non-OADS,/arxiv_data1/oa_pdf/48/c1/mi2013128a.PMC4137743.pdf
"Competing Interests Both authors have completed the Uniﬁed CompetingInterest form at http://www.icmje.org/coi_disclosure.pdf(available on request from the corresponding author) anddeclare: Novartis Pharmaceuticals Corporation fundedthe editorial assistance from Anthemis Consulting Ltdfor the submitted work; AJ has received reimbursementsand funding from pharmaceutical companies includingAstellas, AstraZeneca, Baxter, Novartis, Roche and Sanoﬁand owns stock in Abbott, AstraZeneca, Pﬁzer, Roche andSanoﬁ; DWH has been a speaker for Novartis and Sanoﬁ onissues relating to the impact of drug quality on safety andefﬁcacy.Financial support for medical editorial assistance was provided by Novartis Pharmaceuticals Corporation.",Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.ema.europa.eu/ema/index.jsp?curl =pages/news_and_events/ news/2010/03/news_detail_001010.jsp&mid = WC0b01ac058004d5c1 (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
"Available athttp://www.fda.gov/Safety/Recalls/ucm322901.htm (lastaccessed 18 December 2013).Table 5 Example drug-registration fees Country/area Authority Date Drug registration fee Source Australia Therapeutic Goods Administration 2012 Prescription medicines (application +evaluation) New chemical entity: AU$210 100 New generic product: AU$80 200http://www.tga.gov.au/about/fees-current.htm Europe European Medicines Agency 2012 €267 400 http://www.ema.europa.eu/docs/en_GB/document _library/Other/2012/03/WC500124904.pdf India Central Drugs Standard Control OrganizationNot known; information currently available on website dated2007Imported drug: INR50 000 (approximately US$913/£576)http://cdsco.nic.in/html/Sec_122_A.htm Kenya Pharmacy and Poisons Board, Ministry of HealthCurrent information on website dated 2010Imported: US$1000.",Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
"Fully manufactured in Kenya: US$500 (US$4000 for Good Manufacturing Practiceinspection)http://pharmacyboardkenya.org/?page_id =401 Nigeria National Agency for Food, Drug Administration and Control2011 NGN700 000 (approx.",Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
"US$4500/£2700) every 5 years+5% VAThttp://www.unido.org/ﬁleadmin/user_media/Services/ PSD/BEP/Nigeria_Pharma%20Sector%20Proﬁle_032011_Ebook.pdf Tanzania Food and Drugs Authority 2011/2012 Foreign manufactured products: application fee US$500;registration certiﬁcate US$100per producthttp://pharmabiz.com/Services/ExportImport/ Countries/Tanzania.aspx Uganda National Drug Authority 2010 Foreign manufactured products: US$500.http://pharmabiz.com/Services/ExportImport/ Countries/Uganda.aspx USA Food and Drug Administration Published in 2012, applicable in 2012/2013Application requiring clinical data: US$1 958 800http://www.gpo.gov/fdsys/pkg/FR-2012-08-01/pdf/ 2012-18711.pdf Abbreviations are as follows: INR, Indian rupee; NGN, Nigerian naira; PKR, Pakistani rupee.",Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://www.fda.gov/newsevents/newsroom/pressannouncements/2008/ucm116949.htm (last accessed18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://dineshthakur.com/wp-content/uploads/2013/05/2012.01.25-FDA-Consent-Decree-Press-Release.pdf (last accessed 18December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://www.who.int/medicines/services/counterfeit/faqs/QACounterfeit-October2009.pdf (last accessed 18December 2013).,OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.unodc.org/documents/wdr/WDR_2010/World_Drug_Report_2010_lo-res.pdf (last accessed 18 December 2013).,OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://www.who.int/mediacentre/factsheets/2003/fs275/en/ (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
"Proposal for a directive of the Europeanparliament and of the council amending Directive2001/83/EC as regards the prevention of the entry into thelegal supply chain of medicinal products which are falsiﬁedin relation to their identity, history or source, 2008.Available at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri =SEC:2008:2675:FIN:en:PDF (last accessed 18 December 2013).",Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
2009.Available at http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2009/13384a-eng.php (last accessed18 December 2013).,OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/13584a-eng.php (last accessed 18 December 2013).,OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://www.fda.gov/Safety/Recalls/ucm248552.htm (lastaccessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://ansm.sante.fr/Dossiers-thematiques/Furosemide/Furosemide-Teva-40-mg-comprime/%28offset%29/0 (last accessed 18 December2013).44Health Canada.,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Availableat http://www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/prodpharma/q3a(r)-eng.pdf (last accessed18 December 2013).,OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://private.ich.org/LOB/media/MEDIA422.pdf (last accessed 18 December2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.dawn.com/news/695377/police-body-recommends-action-against-17-people (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.who.int/medicines/publications/drugalerts/DrugSafetyAlert125.pdf(last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Availableat http://www.fda.gov/Drugs/DrugSafety/ucm329951.htm(last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://www.nytimes.com/1990/02/10/us/perrier-recalls-its-water-in-us-after-benzene-is-found-in-bottles.html (lastaccessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.fda.gov/Food/FoodborneIllnessContaminants/ChemicalContaminants/ucm055131.htm# (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.deccanherald.com/content/66392/govt-declares-breast-cancer-drug.html (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://money.cnn.com/2010/01/15/news/companies/over_the_counter_medicine_recall/ (lastaccessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Internal Medicine News 6 December 2010.Available at http://www.internalmedicinenews.com/single-view/methyl-chloride-contamination-found-in-generic-clopidogrel/970bc96188.html (last accessed 18December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
"Available at: http://allafrica.com/stories/201101120547.html (last accessed 3 March 2011).69Mastoraki E, Michalopoulos A, Kriaras I, Mouchtouri E, Falagas ME, Karatza D, Geroulanos S. Incidence ofpostoperative infections in patients undergoing coronaryartery bypass grafting surgery receiving antimicrobialprophylaxis with original and generic cefuroxime.",Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.ema.europa.eu/ema/index.jsp?curl =pages/special_topics/document_listing/ document_listing_000318.jsp&mid =WC0b01ac0580281bf0 (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
"February 9, 2012.Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm291232.htm (lastaccessed 18 December 2013).",Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.ema.europa.eu/ema/index.jsp?curl =pages/ regulation/general/general_content_000408.jsp&mid=WC0b01ac058002958c#Overarchingbiosimilarguidelines (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM112669 (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.cdc.gov/hai/outbreaks/meningitis-map.html (last accessed 19November 2012).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Availableat http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm184502.htm (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
2013.Available at http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf#page =5 (last accessed 18 December 2013).,OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.who.int/mediacentre/factsheets/fs194/en/# (last accessed 18December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://www.wwarn.org/sites/default/ﬁles/WWARNAntimalarialQualityBrochure.pdf (last accessed 18December 2013).,OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.who.int/healthsystems/topics/ﬁnancing/healthreport/34Medicinesrev.pdf (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.who.int/medicines/services/counterfeit/impact/TheNewEstimatesCounterfeit.pdf (lastaccessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
"Medicine regulation – not IP enforcement – can best deliver quality medicines, 2011.Available at http://www.oxfam.org/sites/www.oxfam.org/ﬁles/eye-on-the-ball-medicine-regulation-020211-en.pdf (last accessed 18 December 2013).",Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://www.who.int/mediacentre/factsheets/2003/fs275/en/print.html (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/DrugAlerts/index.htm (last accessed 22 November 2012).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://ec.europa.eu/health/ﬁles/eudralex/vol-1/dir_2011_62/dir_2011_62_en.pdf (lastaccessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.unodc.org/unodc/secured/wdr/wdr2013/World_Drug_Report_2013.pdf (last accessed 18 December 2013).,OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://apps.who.int/medicinedocs/documents/s17069e/s17069e.pdf (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://www.who.int/medicines/publications/WHO_QAMSA_report.pdf (last accessed 18 December2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.ip-watch.org/2011/01/19/who-members-show-dismay-at-delay-on-counterfeit-medicines-group/ (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.who.int/mediacentre/news/releases/2012/wha65_closes_20120526/en/index.html (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.usp.org/around-world/pqm-uspusaid/medicines-quality-database-mqdb (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://www.wwarn.org/aqsurveyor/ (last accessed 18December 2013).,OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.who.int/medicines/services/counterfeit/overview/en/index2.html# (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://www.nature.com/news/pakistani-drug-regulator-destined-to-be-a-failure-1.10380 (last accessed 18December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
"A United Nations Programme managed by WHO, 2010.Available at http://apps.who.int/prequal/ (last accessed 18December 2013).149 World Health Organization.",Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
"Access to HIV/AIDS drugs and diagnostics of acceptable quality, 63rd Edition, 2008.Available at http://apps.who.int/prequal/lists/hiv_suppliers.pdf (last accessed 18 December 2013).",Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
"Multisource (generic) pharmaceutical products: guidelines on registrationrequirements to establish interchangeability, 2006.Available at http://apps.who.int/prequal/info_general/documents/TRS937/WHO_TRS_937_eng.pdf#page =359 (last accessed 18 December 2013).",Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.who.int/medicines/areas/policy/goodgovernance/ENCurbingCorruption4May2010.pdf (last accessed 18December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.who.int/medicines/areas/policy/goodgovernance/AssessmentInstrumentMeastranspENG.PDF (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.who.int/medicines/areas/policy/goodgovernance/5countryAssessment.pdf(last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://www.who.int/medicines/areas/policy/goodgovernance/GGM2010ProgressReport.pdf (lastaccessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.pharmabiz.com/ArticleDetails.aspx?aid=61038&sid =3 (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
"WHO initiates pilot prequaliﬁcation of active pharmaceutical ingredients, 2010.Available at http://apps.who.int/prequal/info_applicants/API/API_communique.pdf (last accessed 18 December2013).",Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://apps.who.int/medicinedocs/documents/s18405en/s18405en.pdf (lastaccessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.in-pharmatechnologist.com/Drug-Delivery/NAFDAC-launches-mobile-anti-counterfeiting-service (last accessed18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://venturebeat.com/2011/03/22/sproxil-lands-1-8-million-to-ﬁght-fake-drugs/ (lastaccessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://sproxil.com/download/for-the-press/2012/PressRelease-SproxilReaches1Mil2012-01-25.pdf (last accessed 18December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://dgft.gov.in/exim/2000/pn/pn10/pn2110.htm (last accessed 18 December 2013).,OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://www.efpia.eu/uploads/Modules/Documents/european_stakeholder_model_esm_publication_june_2012-20120622-007-en-v1.pdf (last accessed 18December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
2013.Available at http://www.edqm.eu/en/eTACT-1466.html (lastaccessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri =OJ:C:2013:068 :0001:0014:EN:PDF (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://ec.europa.eu/health/ﬁles/gmp/2013-02_gdp_for_api_cons.pdf (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
"Available at http://www.gmp-compliance.org/eca_news_3030_7186,7225,7218.html (last accessed 18December 2013).",OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.gao.gov/assets/660/652133.pdf (last accessed 18 December 2013).,OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
2012 Available at http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/UCM298578.pdf(last accessed 18 December 2013).173 Food and Drug Administration.,OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.fda.gov/Drugs/DrugSafety/DrugIntegrityandSupplyChainSecurity/ucm298047.htm (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.thedailystar.net/newDesign/news-details.php?nid =171868 (last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://us.vocuspr.com/ViewAttachment.aspx?EID =bK0ke822q8svy24Psob15tx9 Qclx9ZG5aZ6ZqbADRA4%3D (last accessed 18 December2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available athttp://www.gphf.org/web/en/minilab/index.htm (lastaccessed 18 December 2013).,OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
Available at http://www.aei.org/ﬁles/2010/05/18/SafeMedicinesChest2010.pdf(last accessed 18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
"Available athttp://archive.transparency.org/global_priorities/other_thematic_issues/health/service_delivery/procurement(last accessed 18 December 2013).189 Vian T. Review of corruption in the health sector: theory, methods and interventions.",Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
2009.Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2009/ucm149532.htm (last accessed18 December 2013).,Non-OADS,/arxiv_data1/oa_pdf/68/68/bcp0078-0218.PMC4137817.pdf
"Competing Interests All authors have completed the Uniﬁed Competing Inter-est form at http://www.icmje.org/coi_disclosure.pdf (avail-able on request from the corresponding author) anddeclare: DK, MB, WM and JK had editorial support fromYong-Ling Liu for the submitted work; DK, MB, WM and JKhave been employees of Bayer HealthCare Pharmaceuti-cals in the previous 3 years; no other relationships or activi-ties that could appear to have inﬂuenced the submittedwork.",Non-OADS,/arxiv_data1/oa_pdf/33/85/bcp0078-0353.PMC4137827.pdf
Competing Interests All authors have completed the Uniﬁed Competing Inter-est form at http://www.icmje.org/coi_disclosure.pdf (avail-able on request from the corresponding author) anddeclare: no support from any organization for the submit-ted work; no ﬁnancial relationships with any organizations that might have an interest in the submitted work in theprevious 3 years; no other relationships or activities thatcould appear to have inﬂuenced the submitted work.,Non-OADS,/arxiv_data1/oa_pdf/51/61/bcp0078-0401.PMC4137832.pdf
Available at http://www.who.int/topics/patient_safety/en/ (lastaccessed 20 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/51/61/bcp0078-0401.PMC4137832.pdf
"2013 Available at http://www.hscic.gov.uk/catalogue/PUB11291 (last accessed 1 August 2013).22Kilbridge PM, Alexander L, Ahmad A.",Non-OADS,/arxiv_data1/oa_pdf/51/61/bcp0078-0401.PMC4137832.pdf
2014 Available from: http://psnc.org.uk/dispensing-supply/eps/ (last accessed 6 January2014).,Non-OADS,/arxiv_data1/oa_pdf/51/61/bcp0078-0401.PMC4137832.pdf
2006 Available from:http://www.nrls.npsa.nhs.uk/EasySiteWeb/getresource.axd?AssetID =60036&type =full&servicetype =Attachment (last accessed 20 November 2013).,OADS,/arxiv_data1/oa_pdf/51/61/bcp0078-0401.PMC4137832.pdf
2011 Available from: http://www.fsrh.org/pdfs/CEUguidancedruginteractionshormonal.pdf (lastaccessed 4 November 2013).,OADS,/arxiv_data1/oa_pdf/51/61/bcp0078-0401.PMC4137832.pdf
"Keywords: common variable immunodeﬁciency ,immunoglobulin ,myeloma , primary antibody deﬁciency ,screening ,secondary antibody deﬁciencyAccepted for publication 27 April 2014 Correspondence: S. Jolles, Department ofImmunology, University Hospital of Wales,Cardiff CF14 4XW, Wales, UK.E-mail: jollessr@cardiff.ac.uk Introduction Antibody deﬁciency may be either primary or secondary, and the most common severe primary antibody deﬁciency(PAD) is common variable immunodeﬁciency (CVID),which accounts for the majority (57%) of all symptomaticprimary immunodeﬁciency (PID) cases on the EuropeanSociety for Immunodeﬁciencies (ESID) registry (http://www.esid.org).",Non-OADS,/arxiv_data1/oa_pdf/dc/f5/cei0177-0671.PMC4137851.pdf
"Clinical strategies to reduce diagnostic delay include improved education and awareness of antibody deﬁciencyin both primary and secondary care, patient-centred screen-ing [3], the use of the ‘10 warning signs’ of PID (http://www.info4pi.org) and using computer sorting of diagnosticcodes [4].",Non-OADS,/arxiv_data1/oa_pdf/dc/f5/cei0177-0671.PMC4137851.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f2/cd/cia-9-1269.PMC4137914.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1269–1275Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1269Short reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/CIA.S6619 0Alfonso Castillo-rodríguez1 José Luis Chinchilla- Minguet2 1Faculty of Sport, University of pablo  de olavide, Seville, 2Department  of Didactics of Musical, plastic, and  Corporal expression, University   of Malaga, Malaga, Spain Correspondence: Alfonso Castillo- rodríguez   Faculty of Sport – Edifice 14, University  of pablo de olavide, Carretera Utrera  km 1, Seville 41013, Spain   tel +34 954 977 512   email acasrod1@upo.e sCardiovascular program to improve physical  fitness in those over 60 years old – pilot study Background:  In Spain, more than 50% of 60-year-olds are obese.",Non-OADS,/arxiv_data1/oa_pdf/f2/cd/cia-9-1269.PMC4137914.pdf
"Both phenomena result  in decreased strength and aerobic capacity.5,6 PA such as aerobic and resistance exercises, prevent the ordinary reduction in the  size and number of muscle fibers (sarcopenia).7–9 Regular, vigorous PA also prevents Journal name: Clinical Interventions in Aging Journal Designation: Short Report Y ear: 2014 Volume: 9 Running head verso: Castillo-Rodríguez and Chinchilla-Minguet Running head recto: Cardiovascular program pilot study DOI: http://dx.doi.org/10.2147/CIA.S66190",Non-OADS,/arxiv_data1/oa_pdf/f2/cd/cia-9-1269.PMC4137914.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/cd/cia-9-1269.PMC4137914.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/f2/cd/cia-9-1269.PMC4137914.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/f2/cd/cia-9-1269.PMC4137914.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug, Healthcare and Patient Safety 2014:6 101–108Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  101Original reSearcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DHPS.S6435 9Validating administrative data for the detection   of adverse events in older hospitalized patients Stacy ackroyd-Stolarz1,2 Susan K Bowles3–5 lorri giffin6 1Performance excellence Portfolio,  capital District Health authority,  Halifax, nova Scotia, canada;   2Department of emergency Medicine,  Dalhousie University, Halifax, nova  Scotia, canada;  3geriatric Medicine,  capital District Health authority,  Halifax, nova Scotia, canada;  4college  of Pharmacy and Division of geriatric  Medicine, Dalhousie University, Halifax,  nova Scotia, canada; 5Department of  Pharmacy at capital District Health  authority, Halifax, nova Scotia,  canada;  6South Shore Family Health,  Bridgewater, nova Scotia, canada correspondence: Stacy ackroyd-Stolarz   Department of emergency Medicine,  Queen elizabeth ii Health Sciences  Centre, Halifax Infirmary,  1796 Summer  Street, Suite  355, Halifax, nova Scotia,  canada B3H  3a7  Tel +1 902 473 3565  Fax +1 902 473 3617  email s tacy.ackroyd@cdha.nshealth.c aAbstract:  Older hospitalized patients are at risk of experiencing adverse events including, but  not limited to, hospital-acquired pressure ulcers, fall-related injuries, and adverse drug events.",Non-OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
Or use: http://dvpr.es/1rB3nv i,Non-OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
"Available  from: http://www.cdc.gov/nchs/data/databriefs/db42.pd f. Accessed  March  12, 2014.",OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
"Available  from: http://www.publications.gc.ca/site/eng/103922/publication.htm l.  Last accessed July 14, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
Available  from: http://www.cihi.ca/CIHI-ext-portal/internet/EN/ TabbedContent/ health+system+performance/indicators/performance/cihi01065 7.,OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
"Available from: http://www.ahrq.gov/downloads/pub/advances2/ vol1/Advances-Hougland_26.pd f. Accessed March 11, 2014.",OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
Available from: http://www.cihi.ca/cihi-ext-por - tal/internet/en/document/standards +and+data+submission/ standards/ classification +and+coding/codingclass_icd1 0.,OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
Available  from: https://secure.cihi.,OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
"Available from: http://www.cihi.ca/ CIHI-ext-portal/pdf/internet/CHRP_TNCI_PDF_E N. Accessed Febru - ary 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
Available from: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
Available  from: http://www.cihi.ca/CIHI-ext-portal/inte rnet/EN/TabbedContent/ health+system+performance/indicators/performance/cihi01065 7.,OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
Available from: http://www.cihi.ca/cihi-ext- portal/internet/en/document/standards +and+data+submission/ standards/ classification +and+coding/codingclass_icd1 0.,OADS,/arxiv_data1/oa_pdf/d5/52/dhps-6-101.PMC4137915.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/34/clep-6-277.PMC4137916.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2014:6 277–286Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  277Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S6533 8Chiang Mai University health Worker study   aiming toward a better understanding   of noncommunicable disease development   in Thailand: methods and description of study  population Chaisiri angkurawaranon1,2 anawat Wisetborisut2 Wichuda Jiraporncharoen2 surinporn likhitsathian3 ronnaphob Uaphanthasath2 Patama gomutbutra2 surin Jiraniramai2 Chawin lerssrimonkol2 apinun aramrattanna2 Pat Doyle1 Dorothea nitsch1 1Department of n on-Communicable  Disease Epidemiology, Faculty  of Epidemiology and Population  health, london school of hygiene  and Tropical Medicine, london, UK;   2Department of Family Medicine,   Faculty of Medicine, Chiang Mai  University, Chiang Mai, Thailand;   3Department of Psychiatry, Faculty  of Medicine, Chiang Mai University,   Chiang Mai, Thailand Correspondence: Chaisiri  angkurawaranon   london school of hygiene and Tropical  Medicine, Keppel street, london WC1E  7hT, UK   Tel +44 20 7927 2254   Fax +44 20 7580 6897   Email chaisiri.angkurawaranon@lshtm.",Non-OADS,/arxiv_data1/oa_pdf/8d/34/clep-6-277.PMC4137916.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/8d/34/clep-6-277.PMC4137916.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/38/c0/copd-9-853.PMC4137917.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2014:9 853–861International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  853OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S6704 4airway epithelial platelet-activating factor  receptor expression is markedly upregulated   in chronic obstructive pulmonary disease shakti Dhar shukla1,* sukhwinder singh sohal1,* Malik Quasir Mahmood1 David reid2 hans Konrad Muller1 eugene haydn Walters1 1nhMrC Centre for research  excellence for Chronic respiratory  Disease and lung ageing, school of  Medicine, University of Tasmania,   hobart, Tasmania, australia;   2Queensland Institute of Medical  research, Iron Metabolism laboratory,   Brisbane, Queensland, australia  *shakti Dhar shukla and sukhwinder  singh sohal are joint first authors Correspondence: eugene haydn Walters   nhMrC Centre for research excellence  in Chronic respiratory Disease and  lung ageing, UTas school of Medicine,  Ms1, 17 liverpool street, Private Bag  23,  hobart, Tasmania  7000, australia   Tel +61 3 6226 4805  Fax +61 3 6226 7704  email h aydn.",Non-OADS,/arxiv_data1/oa_pdf/38/c0/copd-9-853.PMC4137917.pdf
References  1. http://www.goldcopd.org [homepage on the Internet].,Non-OADS,/arxiv_data1/oa_pdf/38/c0/copd-9-853.PMC4137917.pdf
"Available from:  http://www.goldcopd.or g. Accessed January  22, 2013.",OADS,/arxiv_data1/oa_pdf/38/c0/copd-9-853.PMC4137917.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/38/c0/copd-9-853.PMC4137917.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/c0/copd-9-853.PMC4137917.pdf
"The reference sequences  were obtained from National Center for  Biotechnology Information (NCBI; Bethesda, MD,  USA) database (http://www.ncbi.nlm.nih.gov/).",OADS,/arxiv_data1/oa_pdf/93/0d/IJBMS-17-441.PMC4137940.pdf
ARMS primer and  accessible on the Cedar Genetics website http://cedar.genetics.soton.ac.uk/public_html/prime r1.html (22) (Table 1).,OADS,/arxiv_data1/oa_pdf/93/0d/IJBMS-17-441.PMC4137940.pdf
"Statistical analysis   Computational and Molecular Population  Geneti cs Lab (CMPG) software, Arlequin version  3.5.1.2 http://cmpg.unibe.ch/software/arlequin3  (Swiss Institute of Bioinformatics, University of  Geneva, Switzerland), was used for population genetic data analysis ( 23).",OADS,/arxiv_data1/oa_pdf/93/0d/IJBMS-17-441.PMC4137940.pdf
TTC -stained slices were  photographed and analyzed by Image -J analysis  software (http://rsb.info.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/70/99/IJBMS-17-454.PMC4137946.pdf
"6 , Jun 2014     400 β-actin molecules from such organisms were compared  in protein blast database (http://blast.ncbi.nlm.nih.gov)  where differences were observed (data not shown).",OADS,/arxiv_data1/oa_pdf/b8/dd/IJBMS-17-396.PMC4137948.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c8/c3/jaa-7-105.PMC4137988.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Asthma and Allergy 2014:7 105–121Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  105Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S4996 0Dietary pattern and asthma: a systematic   review and meta-analysis Nan Lv1 Lan Xiao1 Jun Ma1,2 1Palo Alto Medical Foundation  Research institute, 2Department   of Medicine, Stanford University   School of Medicine, Stanford,    CA, USA Correspondence: Jun Ma   Palo Alto Medical Foundation   Research institute, 795 el Camino Real,   Ames Building, Palo Alto, CA, USA   Tel +1 650 853 4809   Fax +1 650 329 9114   email maj@pamfri.or gBackground:  The literature on the relationship between diet and asthma has largely focused  on individual nutrients, with conflicting results.",Non-OADS,/arxiv_data1/oa_pdf/c8/c3/jaa-7-105.PMC4137988.pdf
Or use: http://dvpr.es/1vD4NE w,Non-OADS,/arxiv_data1/oa_pdf/c8/c3/jaa-7-105.PMC4137988.pdf
"Available from: http://www.cdc.gov/asthma/nhis/01/ table 3-1.ht m.  Accessed March 7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c8/c3/jaa-7-105.PMC4137988.pdf
Available from: http://www.cdc.gov/asthma/nhis/2012/ table 3-1. htm.,Non-OADS,/arxiv_data1/oa_pdf/c8/c3/jaa-7-105.PMC4137988.pdf
Available  from: http://www.cnpp.usda.gov/dietaryguidelines.html.,Non-OADS,/arxiv_data1/oa_pdf/c8/c3/jaa-7-105.PMC4137988.pdf
Available  from: http://www.elsevier.com/online-tools/embase/training-and- support.,Non-OADS,/arxiv_data1/oa_pdf/c8/c3/jaa-7-105.PMC4137988.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/c8/c3/jaa-7-105.PMC4137988.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/c3/jaa-7-105.PMC4137988.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fd/3f/ijn-9-3841.PMC4137990.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3841–3853International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3841OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6463 0Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Fakharzadeh et al Running head recto: Therapeutic effects of MSc1 nanocomplex DOI: http://dx.doi.org/10.2147/IJN.S64630 The therapeutic effects of Msc1 nanocomplex,  synthesized by nanochelating technology,  on experimental autoimmune encephalomyelitic   c57/Bl6 mice saideh Fakharzadeh1 Mohammad ali sahraian2 Maryam hafizi1 somayeh Kalanaky1 Zahra Masoumi1 Mehdi Mahdavi1 Nasser Kamalian3 alireza Minagar4 Mohammad hassan  Nazaran1 1Department of research and  Development, sodour ahrar shargh  company, T ehran, Iran; 2Ms research  center, Neuroscience Institute, Tehran  University of Medical sciences, T ehran,   Iran; 3Department of Pathology,   Medical school of Tehran University  of Medical sciences, T ehran, Iran;   4Department of Neurology, lsU  health sciences centre, shreveport,   la, Usa correspondence: Mohammad hassan  Nazaran   Department of research and  Development, sodour ahrar shargh  company, 2-1 afshin alley, abdollahzade  street, Keshavarz Boulevard, Tehran  11369, Iran Tel +98 21 8899 2123 Fax +98 21 8895 3212 email mnazaran@nanochelatingtechnology.",Non-OADS,/arxiv_data1/oa_pdf/fd/3f/ijn-9-3841.PMC4137990.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fd/3f/ijn-9-3841.PMC4137990.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3853Therapeutic effects of Msc1 nanocomplex Figure S3 scaling of transmission electron microscopy image of Msc1 for nanoparticle size–distribution histogram.,Non-OADS,/arxiv_data1/oa_pdf/fd/3f/ijn-9-3841.PMC4137990.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/dd/dddt-8-1073.PMC4137993.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2014:8 1073–1082Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1073Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6745 6Meclofenamate elicits a nephropreventing effect   in a rat model of ischemic acute kidney injury   by suppressing indoxyl sulfate production   and restoring renal organic anion transporters chika saigo1 Yui nomura1 Yuko Yamamoto1 Masataka sagata1 rika Matsunaga1 hirofumi Jono1,2 Kazuhiko nishi3 hideyuki saito1,2 1Department of clinical  Pharmaceutical sciences, graduate  school of Pharmaceutical sciences,  Kumamoto University, 2Department  of Pharmacy, Kumamoto University  hospital, 3Department of hemo- Dialysis, Kumamoto University  hospital, Kumamoto, Japan correspondence: hideyuki saito   Department of Pharmacy, Kumamoto  University hospital, 1-1-1 honjo,  chuo-ku, Kumamoto,   Kumamoto 860 8556, Japan   Tel/Fax +81 96 373 5820   email saitohide@fc.kuh.kumamoto-u.ac.j pAbstract:  Indoxyl sulfate (IS), a putative low-molecular weight uremic toxin, is excreted in the  urine under normal kidney function, but is retained in the circulation and tissues during renal  dysfunction in acute kidney injury and chronic kidney disease.",Non-OADS,/arxiv_data1/oa_pdf/17/dd/dddt-8-1073.PMC4137993.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/17/dd/dddt-8-1073.PMC4137993.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/dd/dddt-8-1073.PMC4137993.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/b5/ijn-9-3865.PMC4137995.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3865–3874International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3865OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6263 0Preparation, characterization, and optimization  of primaquine-loaded solid lipid nanoparticles Wesley Nyaigoti Omwoyo1,2 Bernhards Ogutu3,4 Florence Oloo3,5 hulda swai6 lonji Kalombo6 Paula Melariri6 geoffrey Maroa Mahanga2 Jeremiah Waweru  gathirwa3,4 1Department of chemistry, Maasai  Mara University, Narok, Kenya;   2Department of chemistry, Jaramogi  Oginga Odinga University of science  and T echnology, Bondo, Kenya; 3center  for research in Therapeutic sciences,   strathmore University, Nairobi, Kenya;   4Kenya Medical research Institute,   Nairobi, Kenya; 5Department of  chemical sciences and T echnology,   T echnical University of Kenya, Nairobi,   Kenya; 6Department of Polymers and  composites, council for scientific   and Industrial research, Pretoria,   south africaAbstract:  Primaquine (PQ) is one of the most widely used antimalarial drugs and is the only  available drug that combats the relapsing form of malaria.",Non-OADS,/arxiv_data1/oa_pdf/88/b5/ijn-9-3865.PMC4137995.pdf
"The failure of mosquito eradication, drug resistance, and  the nonavailability of an effective antimalarial vaccine herald the need for alternative  antiplasmodial therapy, a search for novel antimalarial compounds, or improvement  of the existing antimalarials.3correspondence: Jeremiah Waweru  gathirwa Kenya Medical research Institute,   PO Box 54840, Nairobi 00200, Kenya T el +254 20 2722541 Fax +254 20 2720030 email jgathirwa@yahoo.co mJournal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Omwoyo et al Running head recto: Preparation of primaquine–solid lipid nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S62630",Non-OADS,/arxiv_data1/oa_pdf/88/b5/ijn-9-3865.PMC4137995.pdf
Available from:http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/88/b5/ijn-9-3865.PMC4137995.pdf
Available  from: http://www.who.int/malaria/publications/atoz/artemisinin_resis - tance_containment_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/88/b5/ijn-9-3865.PMC4137995.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/88/b5/ijn-9-3865.PMC4137995.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 3874Omwoyo et al  10.,Non-OADS,/arxiv_data1/oa_pdf/88/b5/ijn-9-3865.PMC4137995.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/db/b1/ijn-9-3855.PMC4137996.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3855–3864International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3855OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6400 8Design, characterization, and clinical evaluation  of argan oil nanostructured lipid carriers   to improve skin hydration Deise Michele Tichota1 ana catarina silva2,3 José Manuel sousa lobo2 Maria helena amaral2 1Federal University of rio grande  do sul, Porto alegre, 2laboratory  of Pharmaceutical T echnology/ centre of research in Pharmaceutical  sciences, Faculty of Pharmacy,   University of Porto, 3Faculty of health  sciences, Fernando Pessoa University,   Porto, Portugal correspondence: ana catarina silva/  Maria helena amaral   laboratory of Pharmaceutical  Technology/centre of research in  Pharmaceutical sciences, Faculty of  Pharmacy, University of Porto, 228 rua  Jorge Viterbo Ferreira, Porto 4050-313,  Portugal   Tel +351 22 042 8624   Fax +351 22 200 3977   email ana.silva@ff.up.p t/hamaral@ff.up.p t Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Tichota et al Running head recto: Clinical evaluation of NLCs for skin hydration DOI: http://dx.doi.org/10.2147/IJN.S64008 Abstract:  Given its advantages in skin application (eg, hydration, antiaging, and protection),  argan oil could be used in both dermatological and cosmetic formulations.",Non-OADS,/arxiv_data1/oa_pdf/db/b1/ijn-9-3855.PMC4137996.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/db/b1/ijn-9-3855.PMC4137996.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 3864Tichota et al  31.,Non-OADS,/arxiv_data1/oa_pdf/db/b1/ijn-9-3855.PMC4137996.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/cd/tcrm-10-641.PMC4137997.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 641–650Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  641Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6155 1The role of erythropoietin stimulating   agents in anemic patients with heart failure:   solved and unresolved questions Alberto Palazzuoli Gaetano Ruocco Marco Pellegrini Carmelo De Gori Gabriele Del Castillo Nicola Giordano Ranuccio Nuti Department of internal Medicine  and Metabolic Diseases, Cardiology  Section, Le Scotte Hospital, University  of Siena, Siena, italy Correspondence: Alberto Palazzuoli   Department of internal Medicine and  Metabolic Diseases, Cardiology Section,  Le Scotte Hospital, viale Bracci,   Siena 5310, italy   Tel +39 577 585 363;   +39 577 585 461   Fax +39 577 233 480   email palazzuoli2@unisi.i tAbstract:  Anemia is a common finding in congestive heart failure (CHF) and is associated  with an increased mortality and morbidity.",Non-OADS,/arxiv_data1/oa_pdf/13/cd/tcrm-10-641.PMC4137997.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/13/cd/tcrm-10-641.PMC4137997.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/cd/tcrm-10-641.PMC4137997.pdf
"Available from: http://www.fda.gov/drugs/ drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ ucm126481.ht m. Accessed July 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/13/cd/tcrm-10-641.PMC4137997.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/cb/ijn-9-3749.PMC4137998.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3749–3770International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3749RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S6561 6Therapeutics with SPION-labeled stem cells   for the main diseases related to brain aging:   a systematic review Larissa T Alvarim1,3,* Leopoldo P Nucci2,* Javier B Mamani1 Luciana C Marti1 Marina F Aguiar1,2 Helio R Silva1,3 Gisele S Silva1 Mariana P Nucci-da-Silva4 elaine A DelBel5,6 Lionel F Gamarra1–3 1Hospital Israelita Albert einstein, São  Paulo, Brazil; 2Universidade Federal de  São Paulo, UNIFeSP , São Paulo, Brazil;   3Faculdade de Ciências Médicas da  Santa Casa de São Paulo, São Paulo,   Brazil; 4Departamento de Radiologia,   Hospital das Clínicas, Universidade  de São Paulo, Brazil; 5Universidade de  São Paulo-Faculdade de Odontologia  de Ribeirão Preto, São Paulo, Brazil;   6NAPNA- Núcleo de Apoio a Pesquisa  em Neurociências Aplicadas, São  Paulo, Brazil *These authors contributed equally   to this work Correspondence: LF Gamarra   Hospital Israelita Albert einstein, Avenida  Albert einstein, no 627, Morumbi, São  Paulo, SP 05651–901, Brazil   Tel +55 11 2151 3727   email lgamarra@einstein.b rJournal name: International Journal of Nanomedicine Journal Designation: Review Y ear: 2014 Volume: 9 Running head verso: Alvarim et al Running head recto: SPION-labeled stem cells for the diseases related to brain aging DOI: http://dx.doi.org/10.2147/IJN.S65616 Abstract:  The increase in clinical trials assessing the efficacy of cell therapy for structural  and functional regeneration of the nervous system in diseases related to the aging brain is well  known.",Non-OADS,/arxiv_data1/oa_pdf/5f/cb/ijn-9-3749.PMC4137998.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5f/cb/ijn-9-3749.PMC4137998.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3770Alvarim et al  86.,Non-OADS,/arxiv_data1/oa_pdf/5f/cb/ijn-9-3749.PMC4137998.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/89/ad/ijn-9-3875.PMC4138000.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 3875–3884International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3875OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6568 2Development of nanofluorapatite polymer-based  composite for bioactive orthopedic implants   and prostheses correspondence: Xiaocong Yao   The First People’s Hospital of Xiaoshang,  Shixinnan Road 199, Hangzhou 311200,  People’s Republic of China   T el +86 571 8380 7999   email hugf1111@163.co m     lili Yang   Department of Orthopaedic Surgery,  Changzheng Hospital, The Second Military  Medical University, Fengyang Road 415,  Shanghai 20003, People’s Republic of  China   T el +86 21 8188 6999   email biomaterbone@1 63.com  gangfeng hu1,2 hui Wang1 Xiaocong Yao1 Dawei Bi1 Gang Zhu1 Songchao Tang2 Jie Wei2 lili Yang3 Peijian T ong4 luwei Xiao4 1The First People’s Hospital of  Xiaoshang, Hangzhou, People’s  Republic of China; 2Key Laboratory  of Ultra-fine Materials, Ministry of  Education, East China University   of Science and T echnology,    Shanghai, People’s Republic   of China; 3Department of Orthopedic  Surgery, Changzheng Hospital, The  Second Military Medical University,   Shanghai, People’s Republic of China;   4Zhejiang Traditional Chinese Medical  University, Hangzhou, People’s  Republic of ChinaJournal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Hu et al Running head recto: Nanofluorapatite polymer composite as bioactive orthopaedic implants DOI: http://dx.doi.org/10.2147/IJN.S65682 Abstract:  Fluorapatite with low solubility is a promising biomaterial due to its structure, which  is similar to hydroxyapatite.",Non-OADS,/arxiv_data1/oa_pdf/89/ad/ijn-9-3875.PMC4138000.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/89/ad/ijn-9-3875.PMC4138000.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3884hu et al References  1.,Non-OADS,/arxiv_data1/oa_pdf/89/ad/ijn-9-3875.PMC4138000.pdf
"Communicative & Integrative Biology 2014; 7:e29429; http://dx.doi.org/10.4161/cib.29429 Commentary on: Watanabe S, Rost BR, Camacho-Pérez M, Davis MW, Söhl-Kielczynski B, Rosenmund C, Jorgensen EM.",Non-OADS,/arxiv_data1/oa_pdf/b5/2e/cib-7-e29429.PMC4138221.pdf
Nature 2013; 504:242-7; http://dx.doi.org/10.1038/nature12809; PMID:24305055 andSchikorski T. Readily releasable vesicles recycle at  the active zone of hippocampal synapses.,OADS,/arxiv_data1/oa_pdf/b5/2e/cib-7-e29429.PMC4138221.pdf
Proc Natl Acad Sci U S A 2014; 111:5415-20; http://dx.doi.org /10.1073/pnas .1321541111; PMID:2470 6 824,OADS,/arxiv_data1/oa_pdf/b5/2e/cib-7-e29429.PMC4138221.pdf
Nat Neurosci 2014; 17:10-6;   PMID:24369372 ; http://dx.doi.org/10.1038/ nn.3578 2.,Non-OADS,/arxiv_data1/oa_pdf/b5/2e/cib-7-e29429.PMC4138221.pdf
J Cell Biol 1979; 81:275-300; PMID:38256 ;  http://dx.doi.org/10.1083/jcb.81.2.275 3.,Non-OADS,/arxiv_data1/oa_pdf/b5/2e/cib-7-e29429.PMC4138221.pdf
Elife 2013; 2:e00723;   PMID:24015355 ; http://dx.doi.org/10.7554/ eLife.00723 5.,Non-OADS,/arxiv_data1/oa_pdf/b5/2e/cib-7-e29429.PMC4138221.pdf
Nature 2013; 504:242-7; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/2e/cib-7-e29429.PMC4138221.pdf
Proc Natl  Acad Sci U S A 2014; 111:5415-20; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b5/2e/cib-7-e29429.PMC4138221.pdf
Nat Neurosci 2001; 4:391-5; PMID:11276229 ;  http://dx.doi.org/10.1038/86042 9.,Non-OADS,/arxiv_data1/oa_pdf/b5/2e/cib-7-e29429.PMC4138221.pdf
J Neurosci Methods 2007; 165:210- 5; PMID:17631969 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b5/2e/cib-7-e29429.PMC4138221.pdf
"In all cases the coating adhesion was broken in  *Correspondence to: Ludek Joska; Email: joskal@vscht.cz Submitted: 12/30/2013; Revised: 05/20/2014; Accepted: 06/05/2014; Published Online: 08/05/2014 http://dx.doi.org/10.4161/biom.29505Properties of titanium-alloyed DLC layers   for medical applications Ludek Joska1,*, Jaroslav Fojt1, Ladislav Cvrcek2, and Vitezslav Brezina3 1Institute of Chemical t echnology p rague; Faculty of Chemical t echnology; t echnicka 5; p rague, Czech Republic; 2Czech t echnical University in p rague; Faculty of e lectrical  engineering; p rague, Czech Republic; 3Masaryk University; Faculty of Medicine; Brno, Czech Republic Keywords:  EIS, XPS, bioactivity, corrosion, titanium doped DLC DLC-type layers offer a good potential for application in medicine, due to their excellent tribological properties,  chemical resistance, and bio-inert character.",Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Biomaterials 2007; 28:1620- 8; PMID:17196649 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
J Biomed  Mater Res B Appl Biomater 2007 ; 83:72-84;  PMID:17285609 ; http://dx.doi.org/10.1002/ jbm.b.30768 4.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Diamond Related Materials   2003 ; 12:583-9; http://dx.doi.org/10.1016/ S0925-9635(03)00081-5 5.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Diamond Related Materials  2003 ; 12:171-7;  http://dx.doi.org/10.1016/S0925-9635(03)00019-0 6.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Diamond  Related Materials  2003 ; 12:166-70; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Surf Coat Tech  2006 ; 200:4543 -8; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Thin Solid Films  2005 ; 475:291-7; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Diamond  Related Materials  2005 ; 14:1277 -88; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Diamond  Related Materials  2005 ; 14:78-85; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Biomaterials   2000 ; 21:449-56; PMID:10674809 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Diamond Related Materials  2008 ; 17:1949 -54;  http://dx.doi.org/10.1016/j.diamond.2008.04.018 13.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Wear   2007 ; 264:368-73; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Appl Surf Sci 2014 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Tribol Int  2012 ; 53:87-97;  http://dx.doi.org/10.1016/j.triboint.2012.04.015 17.,OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Appl Surf Sci 2012 ; 258:3045 -50; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Mater Res Bull 2012 ; 47:843-9; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Physics  Procedia  2011 ; 18:9-15; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Version 4.0; http://srdata.nist.gov/xps2 .,OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
J Solid State Electrochem 2003 ; 7:421-34;  http://dx.doi.org/10.1007/s10008-002-0338-8 26.,OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Appl Surf Sci 2012 ; 258:3415 -9; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Dent Mater   2006 ; 22:275-82; PMID:16054681 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Dent Mater  2009 ; 25:48- 57; PMID:18585776 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Mater Charact 2011 ; 62:938- 42; http://dx.doi.org/10.1016/j.matchar.2011.07.004 31.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Biomaterials   2006 ; 27:2907 -15; PMID:16448693 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Arch Oral Biol 1978 ; 23:329-36; PMID:28719 ;  http://dx.doi.org/10.1016/0003-9969(78)90089-433.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Thin Solid Films  2011 ; 520:793-9; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
J Biomed  Mater Res B Appl Biomater 2012 ; 100:2122 -30;  PMID:22847998 ; http://dx.doi.org/10.1002/ jbm.b.3277736.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Mater  Lett 2002 ; 54:30-6; http://dx.doi.org/10.1016/ S0167-577X(01)00532-8 39.,Non-OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
Biomaterials  2003 ; 24:3069 -77; PMID:12895579 ;  http://dx.doi.org/10.1016/S0142-9612(03)00154-6,OADS,/arxiv_data1/oa_pdf/b1/71/biom-4-e29505.PMC4138222.pdf
"For example, it has been demonstrated that temperature-responsive chitosan hydrogels are suitable matrices for cardiomyocytes transplantation, 8 and chitosan hydrogels can  be also used as injectable cells delivery system to improve myo - cardial performances of infarcted heart.9 Together with mechanical and chemico-physical properties,  topographic cues are particularly important in determining cell phenotypes, especially for tissues that are highly dependent on  *Correspondence to: Lina Altomare; Email: lina.altomare@polimi.it Submitted: 02/05/2014; Revised: 05/23/2014; Accepted: 06/05/2014; Published Online: 06/18/2014http://dx.doi.org/10.4161/biom.29506Design of 2D chitosan scaffolds   via electrochemical structuring Lina Altomare1,2,*, elena Guglielmo1, elena Maria Varoni3, Serena Bertoldi1,2, Andrea Cochis4, Lia Rimondini4,   and Luigi De Nardo1,2 1politecnico di Milano; Department of Chemistry, Materials, and Chemical e ngineering; Milan, Italy; 2INStM - Consorzio Interuniversitario Nazionale per la Scienza e t ecnologia  dei Materiali; Local Unit p olitecnico di Milano; Milan, Italy; 3Clinica o dontoiatrica A.o .",Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Adv Drug Deliv Rev  2011; 63:221-41;  PMID:21277921 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J Clin Invest 2010; 120:20- 8; PMID:20051633 ; http://dx.doi.org/10.1172/ JCI40820 3.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Nat Med 2006; 12:452- 8; PMID:16582915 ; http://dx.doi.org/10.1038/ nm1394 4.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Cell  Mol Life Sci 2012; 69:2635-56; PMID:22388688 ;  http://dx.doi.org/10.1007/s00018-012-0942-4 5.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Adv Mater 2009; 21:3307- 29; PMID:20882499 ; http://dx.doi.org/10.1002/ adma.2008021066.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J R Soc Interface 2007; 4:999-1030; PMID:17412675 ;  http://dx.doi.org/10.1098/rsif.2007.0220 7.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Biotechnol Adv 2008; 26:1- 21; PMID:17884325 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Tissue Eng Part  A 2010; 16:1303-15; PMID:19905874 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Tissue Eng Part A 2009; 15:1437- 47; PMID:19061432 ; http://dx.doi.org/10.1089/ten.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Biomaterials 2003; 24:2463-76;  PMID:12695073 ;  http://dx.doi.org/10.1016/S0142-9612(02)00644-0 11.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J Biomed  Mater Res 2000; 53:267-75; PMID:10813767 ;  http://dx.doi.org/10.1002/(SICI)1097-4636(2000)53:3<267::AID-JBM12>3.0.CO;2-J 12.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Biomaterials 1997; 18:1573-83;  PMID:9613804 ;  http://dx.doi.org/10.1016/S0142-9612(97)00144-0 13.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J Cell Biol 2004; 166:877- 87; PMID:15364962 ; http://dx.doi.org/10.1083/ jcb.200405004 14.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Proc Natl Acad Sci U S A  2005; 102:11571-2;  PMID:16091458 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Biomaterials  2012; 33:6943-51;  PMID:22800539 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Acta Biomater 2010; 6:1948-57;  PMID:20040385 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
BMC Biotechnol 2009; 9:34; PMID:19368709 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Nano Lett 2006; 6:537-42;  PMID:16522058 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Biomaterials 1998; 19:1945- 55; PMID:9863528 ; http://dx.doi.org/10.1016/ S0142-9612(98)00099-4 22.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J Biomed Mater Res 1993; 27:183- 9; PMID:8382203 ; http://dx.doi.org/10.1002/ jbm.820270207 23.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Biomaterials 1999;  20:1133-42;  PMID:10382829 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J Mater Sci Mater Med 2011; 22:51- 62; PMID:21052794 ; http://dx.doi.org/10.1007/ s10856-010-4177-3 25.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Biomaterials 1993; 14:323-30;  PMID:8507774 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Mater Lett 2012; 78:18-21; http://dx.doi.org/10.1016/j.matlet.2012.03.035 28.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Carbohydr Polym 2009; 77:1-9; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J R Soc Interface 2010; 7(Suppl 5):S581-613;  PMID:20504802 ; http://dx.doi.org/10.1098/ rsif.2010.0156.focus 30.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Prog Mater Sci 2007; 52:1-61; http://dx.doi.org/10.1016/j.pmatsci.2006.07.001 31.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Mater Lett 2009; 63:2253-6;  http://dx.doi.org/10.1016/j.matlet.2009.07.046 32.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J Biomed Mater Res A 2003; 66:411-6; PMID:12889012 ; http://dx.doi.org/10.1002/ jbm.a.10571 33.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Surf Coat Tech 2011; 205:5260-8; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Mater Lett 2011; 65:1463-5; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Biomacromolecules 2013; 14:3355-69; PMID:24001091 ; http://dx.doi.org/10.1021/ bm401021b 39.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Adv  Drug Deliv Rev 2010; 62:83-99; PMID:19799949 ;  http://dx.doi.org/10.1016/j.addr.2009.07.019 41.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J Biomater Sci Polym Ed 2001; 12:835-50;  PMID:11718480 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Biomacromolecules 2004; 5:162- 8; PMID :14715022 ; http://dx.doi.org/10.1021/ bm034286m 43.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J Polym Sci  2000; 38:2804-14; http://dx.doi.org/10.1002/1099- 0518(20000801)38:15<2804::AID-POLA210>3.0.CO;2-Y44.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Colloids Surf A Physicochem Eng Asp  2006; 279:196-207; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J Hazard Mater 2009; 168:1053-8; PMID:19342166 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Hydrometallurgy 2010; 104:150-5; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J Biomater Sci Polym Ed 2005;  16:791-807;  PMID:16028597 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J Biomater Sci Polym Ed 2014; 25:32-50;  PMID:24007370 ; http://dx.doi.org /10.1080/09205063.2013.833441 51.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J Appl Polym Sci 2003; 89:306-17; http://dx.doi.org/10.1002/app.12090 52.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Acta Mater 2001; 49:2975-9; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Biomaterials 1996;  17:1647-57;  PMID:8866026 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Anal Chem  2009; 81:5364-72;  PMID:19473012 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
J Mater Chem 2011; 21:3865-71; http://dx.doi.org/10.1039/ c0jm03075a,Non-OADS,/arxiv_data1/oa_pdf/b0/8b/biom-4-e29506.PMC4138223.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.044024.113.© 2014 Kaiser et al.,OADS,/arxiv_data1/oa_pdf/38/90/1351.PMC4138318.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.LETTER TO THE EDITOR RNA 20:1351 –1355; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1351",Non-OADS,/arxiv_data1/oa_pdf/38/90/1351.PMC4138318.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.042754.113.© 2014 Mitra et al.,OADS,/arxiv_data1/oa_pdf/9a/b0/1356.PMC4138319.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.BIOINFORMATICS 1356 RNA 20:1356 –1368; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/9a/b0/1356.PMC4138319.pdf
"Specifically, both theRNA-Seq and the miRNA-Seq expression profiles from the samesamples were retrieved from TCGA (https://tcga-data.nci.nih.gov/tcga/) (see Supplemental Tables S1, S2 for more details).",OADS,/arxiv_data1/oa_pdf/9a/b0/1356.PMC4138319.pdf
"Normalized miRNA andmatched gene expression profiles were directly obtained from theTCGA data portal (https://tcga-data.nci.nih.gov/tcga/) (see Supple-mental Tables S1, S5 for more detail).",OADS,/arxiv_data1/oa_pdf/9a/b0/1356.PMC4138319.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.044792.114.© 2014 Gu et al.,OADS,/arxiv_data1/oa_pdf/17/bc/1369.PMC4138320.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.BIOINFORMATICS RNA 20:1369 –1375; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1369",Non-OADS,/arxiv_data1/oa_pdf/17/bc/1369.PMC4138320.pdf
"from TarBase (http://diana.imis.athenainnovation.gr/DianaTools/, version 6.0) (Vergoulis et al.2012), miRTarBase (http://mirtarbase.mbc.nctu.edu.tw/) (Hsu et al.2011), StarBase (http://starbase.sysu.edu.cn/) (Yang et al.",OADS,/arxiv_data1/oa_pdf/17/bc/1369.PMC4138320.pdf
"2011),and MirRecords (http://mirecords.biolead.org) (Xiao et al.",OADS,/arxiv_data1/oa_pdf/17/bc/1369.PMC4138320.pdf
"We also downloaded computationally predicted miRNA targets in C. elegans ,D. melanogaster ,M. musculus , and H. sapiens from TargetScan (http://www.targetscan.org, version 6.2) (Lewiset al.",OADS,/arxiv_data1/oa_pdf/17/bc/1369.PMC4138320.pdf
Data on miRNA targets in A. thaliana were obtained from psRNATarget (http://plantgrn.noble.org/psRNATarget/) (Daiand Zhao 2011).,OADS,/arxiv_data1/oa_pdf/17/bc/1369.PMC4138320.pdf
The Gene ID Conversion Tool (http://david.abcc.ncifcrf.gov/conversion.jsp) (Huang da et al.,OADS,/arxiv_data1/oa_pdf/17/bc/1369.PMC4138320.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.042309.113.© 2014 Diao et al.,OADS,/arxiv_data1/oa_pdf/67/a6/1376.PMC4138321.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/67/a6/1376.PMC4138321.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.041954.113.© 2014 Sinha et al.,OADS,/arxiv_data1/oa_pdf/a6/5e/1386.PMC4138322.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/a6/5e/1386.PMC4138322.pdf
The operon annotations and chromosomal coordinates for the C. elegans operons were extracted from the gff file corresponding to release WS239 of Wormbase(ftp://ftp.wormbase.org/pub/wormbase/species/c_elegans/gff/).,OADS,/arxiv_data1/oa_pdf/a6/5e/1386.PMC4138322.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.045302.114.© 2014 Rouya et al.,OADS,/arxiv_data1/oa_pdf/7b/88/1398.PMC4138323.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/7b/88/1398.PMC4138323.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/7b/88/1398.PMC4138323.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.044149.113.© 2014 Cornett and Lutz This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http:// rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/84/8e/1419.PMC4138325.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/84/8e/1419.PMC4138325.pdf
"These predictions were based upon two algorithmic databases, miRanda (http://www.microRNA.org) and TargetScan (http://www.targetscan .org).",OADS,/arxiv_data1/oa_pdf/84/8e/1419.PMC4138325.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.045757.114.,OADS,/arxiv_data1/oa_pdf/66/f5/1431.PMC4138326.pdf
"Freely availableonline through the RNA Open Access option.© 2014 Zhou and Rigoutsos This article, published in RNA , is available un- der a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/66/f5/1431.PMC4138326.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.044404.114.© 2014 Huang et al.,OADS,/arxiv_data1/oa_pdf/22/af/1440.PMC4138327.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/22/af/1440.PMC4138327.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/22/af/1440.PMC4138327.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.046144.114.© 2014 Bouchard and Legault This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/3c/b5/1451.PMC4138328.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/3c/b5/1451.PMC4138328.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.045252.114.This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.,Non-OADS,/arxiv_data1/oa_pdf/5a/3c/1465.PMC4138329.pdf
"After 12 months, it is available under aCreative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/5a/3c/1465.PMC4138329.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.045781.114.© 2014 Talhouarne and Gall This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/03/7a/1476.PMC4138330.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/03/7a/1476.PMC4138330.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2014, 6: 24800 - http://dx.doi.org/10.3402/jom.v6.24800 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f9/a3/JOM-6-24800.PMC4138498.pdf
"List of gingipain inhibitors with references N-terminal prodomain (NPD) (9 /C113) Proteinaceous protease inhibitors (14 /C120) Viruses (21)Rice-derived inhibitors (22, 23)Proteins, peptides, and protein-derived peptides: Lactoferrin (24)Histatin (25)k-casein (26) Cyanate hydratase-derived peptide (22) Peptide analogues: Aza-peptide Michael acceptors (27)A7156 (28)KYT inhibitors (29)DX-9065a (30, 31)Chloromethane and chloromethyl ketones (32, 33)FA-70C1 (34) Antibiotics and antiseptics (35 /C142) Sword bean extract (SBE) and canavanine (43, 44)Cranberry-derived polyphenols (46 /C149) Green tea-derived polyphenols (50 /C159) Myrothamnus flabellifolia -extract (60) IgY and vaccines (42, 61 /C181) Other bacteria (82)Ingar Olsen and Jan Potempa 2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24800 - http://dx.doi.org/10.3402/jom.v6.24800",Non-OADS,/arxiv_data1/oa_pdf/f9/a3/JOM-6-24800.PMC4138498.pdf
"This implies conserva- tion of the tertiary structure, including an exposed reactiveStrategies for the inhibition of gingipains Citation: Journal of Oral Microbiology 2014, 6: 24800 - http://dx.doi.org/10.3402/jom.v6.24800 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f9/a3/JOM-6-24800.PMC4138498.pdf
"(12).Ingar Olsen and Jan Potempa 4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24800 - http://dx.doi.org/10.3402/jom.v6.24800",Non-OADS,/arxiv_data1/oa_pdf/f9/a3/JOM-6-24800.PMC4138498.pdf
‘-’ gaps introduced into sequences to facilitate the alignment using the ClustalW program (http://embnet.vital-it.ch/software/ClustalW .html).,Non-OADS,/arxiv_data1/oa_pdf/f9/a3/JOM-6-24800.PMC4138498.pdf
"(b) The crystal structure of RATI (PDB database: 1B1U) .The reactive site residue Arg34 is shown in ball-and-stick representation in purple.Strategies for the inhibition of gingipains Citation: Journal of Oral Microbiology 2014, 6: 24800 - http://dx.doi.org/10.3402/jom.v6.24800 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f9/a3/JOM-6-24800.PMC4138498.pdf
"This inhibitor and the peptidyl chloromethanesIngar Olsen and Jan Potempa 6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24800 - http://dx.doi.org/10.3402/jom.v6.24800",Non-OADS,/arxiv_data1/oa_pdf/f9/a3/JOM-6-24800.PMC4138498.pdf
"gingivalis and F. nucleatum.Strategies for the inhibition of gingipains Citation: Journal of Oral Microbiology 2014, 6: 24800 - http://dx.doi.org/10.3402/jom.v6.24800 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f9/a3/JOM-6-24800.PMC4138498.pdf
"Immunization with RgpA stimulated theproduction of HA domain-specific antibodies, whichIngar Olsen and Jan Potempa 8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24800 - http://dx.doi.org/10.3402/jom.v6.24800",Non-OADS,/arxiv_data1/oa_pdf/f9/a3/JOM-6-24800.PMC4138498.pdf
"denticola also produce proteinases, future research should investigatetheir susceptibility to gingipain inhibitors as well.Strategies for the inhibition of gingipains Citation: Journal of Oral Microbiology 2014, 6: 24800 - http://dx.doi.org/10.3402/jom.v6.24800 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f9/a3/JOM-6-24800.PMC4138498.pdf
"Dibasic (amidinoaryl) propanoic acidIngar Olsen and Jan Potempa 10 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24800 - http://dx.doi.org/10.3402/jom.v6.24800",Non-OADS,/arxiv_data1/oa_pdf/f9/a3/JOM-6-24800.PMC4138498.pdf
"ClinDiagn Lab Immunol 2000; 7: 31 /C19.Strategies for the inhibition of gingipains Citation: Journal of Oral Microbiology 2014, 6: 24800 - http://dx.doi.org/10.3402/jom.v6.24800 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/f9/a3/JOM-6-24800.PMC4138498.pdf
"J Oral Microbiol 2011; 3: 8396. doi: 10.3402.jom.v3iO.8396.Ingar Olsen and Jan Potempa 12 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 24800 - http://dx.doi.org/10.3402/jom.v6.24800",Non-OADS,/arxiv_data1/oa_pdf/f9/a3/JOM-6-24800.PMC4138498.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bd/8f/srep06137.PMC4138515.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6137 | DOI: 10.1038/srep06137 7",Non-OADS,/arxiv_data1/oa_pdf/bd/8f/srep06137.PMC4138515.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6134 | DOI: 10.1038/srep06134 6",Non-OADS,/arxiv_data1/oa_pdf/18/29/srep06134.PMC4138516.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/36/ce/srep06132.PMC4138518.pdf
Preprint at http://arxiv.org/abs/1301.0330 (2013).,Non-OADS,/arxiv_data1/oa_pdf/45/51/srep06106.PMC4138522.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/45/51/srep06106.PMC4138522.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6106 | DOI: 10.1038/srep06106 6",Non-OADS,/arxiv_data1/oa_pdf/45/51/srep06106.PMC4138522.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/90/9e/srep06098.PMC4138523.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/ed/main.PMC4138544.pdf
"Consent NA Sample source location NA Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE52453 .Experimental design, materials and methods Cell culture and KSHV reactivation in iSLK.rKSHV219 cells rKSHV.219 virus is latently infected in iSLK.rKSHV219 cell line, de- rived from iSLK cell line, as previously described by [4].",OADS,/arxiv_data1/oa_pdf/de/ed/main.PMC4138544.pdf
http://dx.doi.org/10.1016/j.gdata.2014.06.006 2213-5960/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/de/ed/main.PMC4138544.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/ed/main.PMC4138544.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/de/ed/main.PMC4138544.pdf
Samples were hybridized to the DNA microarray according to NimbleGen's in- structions ( http://www.nimblegen.com/technology/index.html ).,OADS,/arxiv_data1/oa_pdf/de/ed/main.PMC4138544.pdf
Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/anie.201304686.,Non-OADS,/arxiv_data1/oa_pdf/a6/01/anie0052-12187.PMC4138556.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/8c/74/JOS-3-68.PMC4138789.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/ca/fa/JOS-3-81.PMC4138791.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/2e/81/JOS-3-89.PMC4138792.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S192Implementation and impact of ICD‑10 (Part II) Gazanfar Rahmathulla, H. Gordon Deen, Judith A. Dokken1, Stephen M. Pirris, Mark A. Pichelmann,  Eric W .",Non-OADS,/arxiv_data1/oa_pdf/08/f1/SNI-5-192.PMC4138807.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/192/137182 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.137182  Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/08/f1/SNI-5-192.PMC4138807.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAHyperosmolar and methotrexate therapy avoiding surgery in the  acute presentation of primary central nervous system lymphoma Bryan S. Lee, Rupa G. Juthani, Andrew T .",Non-OADS,/arxiv_data1/oa_pdf/b1/6e/SNI-5-175.PMC4138808.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/175/136741 Copyright: © 2014 Lee BS.,Non-OADS,/arxiv_data1/oa_pdf/b1/6e/SNI-5-175.PMC4138808.pdf
"Surgical Neurology International Editor: Marcelo Platas, Hospital Presidente Perón,  Buenos AiresOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Revista Argentina de Neurocirugia , a supplement to SNIS256Case Report Ependimoma myxopapilar sacro gigante con osteolisis Giant osteolitic sacral myxopapillary ependymoma Pablo Ajler, Federico Landriel, Ezequiel Goldschmidt, Álvaro Campero1, Claudio Yampolsky Servicio de Neurocirugía, Hospital Italiano de Buenos Aires, 1Servicio de Neurocirugía, Hospital Ángel Padilla, Tucumán, Argentina E-mail: *Pablo Ajler - pablo.ajler@hospitalitaliano.org.ar; Federico Landriel - federico.landriel@hospitalitaliano.org.ar; Ezequiel Goldschmidt - zequiel.gold - schmidt@hospitalitaliano.org.ar; Álvaro Campero - alvarocampero@yahoo.com.ar; Claudio Yampolsky - claudio.yampolsky@hospitalitaliano.org.ar   *Corresponding author Received: 27 February 14  Accepted: 10 April 14  Published: 04 August 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.137952  Quick Response Code: Abstract Objective: Ependymomas are usually intramedullary tumors.",Non-OADS,/arxiv_data1/oa_pdf/f8/3f/SNI-5-256.PMC4138816.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/6/256/137952,Non-OADS,/arxiv_data1/oa_pdf/f8/3f/SNI-5-256.PMC4138816.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAS203Resection of an oculomotor nerve cavernous angioma Sami Obaid1, Shu Li1,2, Daniel Denis1, Alexander G. Weil1, Michel W .",Non-OADS,/arxiv_data1/oa_pdf/2b/ef/SNI-5-203.PMC4138817.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/203/137754 Copyright: © 2014 Obaid S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/2b/ef/SNI-5-203.PMC4138817.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAS181Intramedullary melanotic schwannoma: Case report and review  of the literature Szu‑ Yen Pan, Yu‑Ching Cheng1, Ting‑Hsien Kao Departments of Neurosurgery, and 1Radiology, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.",Non-OADS,/arxiv_data1/oa_pdf/5d/d4/SNI-5-181.PMC4138818.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/181/136742 Copyright: © 2014 Pan S. This is an open -access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/5d/d4/SNI-5-181.PMC4138818.pdf
"Surgical Neurology International Editor: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International  S185Migration to the ICD‑10 coding system: A primer for spine  surgeons (Part 1) Gazanfar Rahmathulla, H. Gordon Deen, Judith A. Dokken1, Stephen M. Pirris, Mark A. Pichelmann,  Eric W .",Non-OADS,/arxiv_data1/oa_pdf/ed/62/SNI-5-185.PMC4138819.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/4/185/137181 Copyright: © 2014 Rahmathulla G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/ed/62/SNI-5-185.PMC4138819.pdf
The link is http://www.cms.gov/ICD10.,Non-OADS,/arxiv_data1/oa_pdf/ed/62/SNI-5-185.PMC4138819.pdf
"Santa Monica, CA: RAND Corporation Available from: http://www.rand.org/ pubs/technical_reports/TR132.html.",Non-OADS,/arxiv_data1/oa_pdf/ed/62/SNI-5-185.PMC4138819.pdf
Available from: Available from: http://www.ehcca.,Non-OADS,/arxiv_data1/oa_pdf/ed/62/SNI-5-185.PMC4138819.pdf
"Available from: http://www.careguidelines.com/sites/default/ files/whitepaper_icd_10_savings.pdf.Appendix 2: Medical and surgical section Character 3‑root operations Alteration Excision Release Bypass Extirpation Removal Change Fragmentation Repair Control Fusion Replacement Creation Insertion Reposition Destruction Inspection Resection Detachment Map Restriction Dilation Occlusion Revision Division Reattachment Supplement Drainage Transfer Transplantation Coded according to exact procedure objective Composite terms not root operations e.g., sigmoidectomy Multiple codes in same surgery if multiple root operations on the same  parts, multiple roots on different parts, intended rot attempted but the  need to convert to another procedure thus root operation REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/ed/62/SNI-5-185.PMC4138819.pdf
Available from: https://www.cms.gov/ ICD10/11b1_2011 ICD10CM_and_GEMs.asp.,OADS,/arxiv_data1/oa_pdf/ed/62/SNI-5-185.PMC4138819.pdf
"Surgical Neurology International  SNI: Revista Argentina de Neurocirug ía, a supplement to SNIEditor: Marcelo Platas, Hospital Presidente Perón,  Buenos AiresOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comS247Original Article Síndrome del Outlet Torácico: ¿Una Patología Siempre  Quirúrgica?",Non-OADS,/arxiv_data1/oa_pdf/52/7f/SNI-5-247.PMC4138820.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/6/247/137950 Copyright: © 2014 Socolovsky M.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/52/7f/SNI-5-247.PMC4138820.pdf
"Surgical Neurology International Editor: Marcelo Platas, Hospital Presidente Perón,  Buenos AiresOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Revista Argentina de Neurocirugia , a supplement to SNIS260Original Article Tratamiento Quirúrgico de los Meningiomas del Foramen Óptico,  Técnicay Resultados de una Serie de 18 Pacientes Surgical treatment of optic foraminal meningiomas, surgical  technique and outcomes from a series of 18 patients Ezequiel Goldschmidt, Pablo Ajler, Álvaro Campero1, Federico Landriel, Maximiliano Sposito,  Antonio Carrizo  Departamento de Neurocirugía, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 1Departamento de Neurocirugía, Hospital Padilla,   Tucumán, Argentina E‑mail: Ezequiel Goldschmidt ‑  ezequiel.goldschmidt@hospitalitaliano.org.ar; *Pablo Ajler ‑  pablo.ajler@hospitalitaliano.org.ar;   Álvaro Campero ‑  alvarocampeo@yahoo.com.ar; Federico Landriel ‑ federico.landriel@hospitalitaliano.org.ar; Maximiliano Sposito ‑  maxi.sposito@gmail.com;  Antonio Carrizo ‑  antonio.carrizo@hospitalitaliano.org.ar   *Corresponding author Received: 27 February 14  Accepted: 11 April 14  Published: 04 August 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.137960  Quick Response Code: Copyright: © 2014  Goldschmidt E. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.This article may be cited as:   Goldschmidt E, Ajler P , Campero A, Landriel F , Sposito M, Carrizo A. Tratamiento Quirúrgico de los Meningiomas del Foramen Óptico, Técnicay Resultados de una Serie de 18  Pacientes.",Non-OADS,/arxiv_data1/oa_pdf/87/29/SNI-5-260.PMC4138821.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/6/260/137960 Abstract Introduction:  Optic foraminal meningiomas produce a rapid deterioration of visual  function even when its size is small, thus  diagnosis and management differ from  other clinoideal meningiomas.",Non-OADS,/arxiv_data1/oa_pdf/87/29/SNI-5-260.PMC4138821.pdf
Available: http://www.ncbi.nlm.nih.gov/pubmed/15399170.,Non-OADS,/arxiv_data1/oa_pdf/87/29/SNI-5-260.PMC4138821.pdf
Available: http://www.ncbi.nlm.nih.gov/pubmed/15402633.,Non-OADS,/arxiv_data1/oa_pdf/87/29/SNI-5-260.PMC4138821.pdf
Available: http://www.ncbi.nlm.nih.gov/ pubmed/13552380.,Non-OADS,/arxiv_data1/oa_pdf/87/29/SNI-5-260.PMC4138821.pdf
Available: http://www.ncbi.nlm.nih.gov/ pubmed/13571783.,Non-OADS,/arxiv_data1/oa_pdf/87/29/SNI-5-260.PMC4138821.pdf
Available: http://www.ncbi.nlm.nih.gov/pubmed/8795775.,Non-OADS,/arxiv_data1/oa_pdf/87/29/SNI-5-260.PMC4138821.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAS208Unusual cause of non‑discogenic sciatica: Foraminal lumbar root  schwannoma C. Karekezi, K. Egu, B. O. Djoubairou, M. Boutarbouch, A. El Ouahabi Department of Neurosurgery, Mohamed Vth University, School of Medicine, Hôpital des Spécialités ONO, CHU Ibn Sina, Rabat 10100, Morocco E‑mail: *C. Karekezi ‑ clairekarekezi@gmail.com; K. Egu ‑ egukomi@gmail.com;   B. O. Djoubairou ‑ bendjoubairou@yahoo.fr;   M. Boutarbouch ‑ mahjouba.boutarbouch@gmail.com; A. El Ouahabi ‑ elouahabi.a@hotmail.com,   *Corresponding author Received: 14 December 13  Accepted: 09 June 14  Published: 30 July 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.137755  Quick Response Code: Abstract Background:  Schwannomas are tumors of peripheral nerves that develop from the  nerve sheath.",Non-OADS,/arxiv_data1/oa_pdf/2e/ff/SNI-5-208.PMC4138822.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/208/137755 Copyright: © 2014 Karekezi C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/2e/ff/SNI-5-208.PMC4138822.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAS199Endovascular treatment of fusiform A2 aneurysm with parent  artery occlusion Anand Alurkar, Lakshmi Sudha Prasanna Karanam, Sagar Oak, Suresh Nayak Department of Neurointervention, King Edward Memorial Hospital, Pune, Maharashtra, India  E‑mail:  Anand Alurkar ‑ anandalurkar@gmail.com; *Lakshmi Sudha Prasanna Karanam ‑ drklsp@gmail.com; Sagar Oak ‑ amru_84@yahoo.com;   Suresh Nayak ‑ vhpltd@hotmail.com   *Corresponding author Received: 20 February 14  Accepted: 03 June 14  Published: 30 July 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.137752  Quick Response Code: Abstract Background: A2 aneurysms are rare with a reported incidence of <1% of the  intracranial aneurysms.",Non-OADS,/arxiv_data1/oa_pdf/d7/3c/SNI-5-199.PMC4138823.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/199/137752 Copyright: © 2014 Alurkar A.,Non-OADS,/arxiv_data1/oa_pdf/d7/3c/SNI-5-199.PMC4138823.pdf
"Surgical Neurology International Editor: Marcelo Platas, Hospital Presidente Perón,  Buenos AiresOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com SNI: Revista Argentina de Neurocirugia, a supplement to SNIS232Abstract Background:  Tremor may be a disabling disorder and pharmacologic treatment  is the first‑line therapy for these patients.",Non-OADS,/arxiv_data1/oa_pdf/07/b3/SNI-5-232.PMC4138824.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/6/232/137944 Copyright: © 2014 Bendersky D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/07/b3/SNI-5-232.PMC4138824.pdf
Available  at: http://www.prd -journal.com/article/S1353-8020 (12)00233-7/abstract.,Non-OADS,/arxiv_data1/oa_pdf/07/b3/SNI-5-232.PMC4138824.pdf
Available at: http://onlinelibrary.wiley.com/doi/10.1111/ j.1525-1403.2012.00503.x/abstract.,Non-OADS,/arxiv_data1/oa_pdf/07/b3/SNI-5-232.PMC4138824.pdf
Available at: http://journals.lww.com/neurosurgery/pages/articleviewer.aspx?year=9000 and issue=00000 and  article=98959 and type=abstract.,Non-OADS,/arxiv_data1/oa_pdf/07/b3/SNI-5-232.PMC4138824.pdf
"Surgical Neurology International  SNI: Revista Argentina de Neurocirugia , a supplement to SNIEditor: Marcelo Platas, Hospital Presidente Perón,  Buenos AiresOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comS267T echnical Note Planificación Neuroquirúrgica con Software Osirix Neurosurgical planning using osirix software Sebastián Gastón Jaimovich1,2, Martin Guevara1, Sergio Pampin2, Roberto Jaimovich2,  Javier Luis Gardella1 1División de Neurocirugía, Hospital Juan A. Fernandez, 2Servicio de Neurocirugía Pediátrica, FLENI Neuroscience Institute, Ciudad Autónoma de Buenos Aires,  Argentina E‑mail: *Sebastián Gastón Jaimovich ‑ sebastianjaimovich@gmail.com; Martin Guevara ‑ martinguevara2@gmail.com; Sergio Pampin ‑ wati.pampin@gmail.com;   Roberto Jaimovich ‑ robjai@hotmail.com; Javier Luis Gardella ‑ gardellajavier@gmail.com   *Corresponding author Received: 28 February 14  Accepted: 24 April 14  Published: 04 August 14 Copyright: © 2014 Jaimovich SG.",Non-OADS,/arxiv_data1/oa_pdf/ae/b2/SNI-5-267.PMC4138825.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/6/267/137970 Abstract Introduction:  Anatomical individuality is key to reduce surgical trauma and obtain  a better outcome.,Non-OADS,/arxiv_data1/oa_pdf/ae/b2/SNI-5-267.PMC4138825.pdf
"Surgical Neurology International  SNI: Revista Argentina de Neurocirugia , a supplement to SNIEditor: Marcelo Platas, Hospital Presidente Perón,  Buenos AiresOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comS211Review Article Cirugía de los trastornos del comportamiento: el estado del arte Surgery for behavioral disorders: the state of the art Claudio Yampolsky, Damián Bendersky Servicio de Neurocirugía, Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina  E‑mail:  Damián Bendersky ‑ damianbendersky@hotmail.com; *Claudio Yampolsky ‑ claudio.yampolsky@hospitalitaliano.org.ar   *Corresponding author Received: 04 August 13  Accepted: 15 August 13  Published: 04 August 14 Copyright: © 2014 Yampolsky C. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distri ‑ bution, and reproduction in any medium, provided the original author and source are credited.This article may be cited as:   Yampolsky C, Bendersky D. Cirugía de los trastornos del comportamiento: el estado del arte.",Non-OADS,/arxiv_data1/oa_pdf/05/81/SNI-5-211.PMC4138826.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/6/211/137936 Abstract Background:  Surgery for behavioral disorders (SBD) is becoming a more common  treatment since the development of neuromodulation techniques.,Non-OADS,/arxiv_data1/oa_pdf/05/81/SNI-5-211.PMC4138826.pdf
Available from:  http://www.sciencedirect.com/science/article/pii/S1878875012006377.,Non-OADS,/arxiv_data1/oa_pdf/05/81/SNI-5-211.PMC4138826.pdf
Available from: http://www.sciencedirect.com/science/article/pii/ S1878875012007802.,Non-OADS,/arxiv_data1/oa_pdf/05/81/SNI-5-211.PMC4138826.pdf
Available from: http://www.iofbonehealth.,Non-OADS,/arxiv_data1/oa_pdf/b6/3c/IJEM-18-441.PMC4138894.pdf
Available from: http://www.qfracture.,Non-OADS,/arxiv_data1/oa_pdf/b6/3c/IJEM-18-441.PMC4138894.pdf
Available from: http://www.ijem.in/backissues.asp.,Non-OADS,/arxiv_data1/oa_pdf/35/83/IJEM-18-443.PMC4138895.pdf
Available from: http://www.en.wikipedia.org/wiki/ Purple#Associations_and_symbolism.,Non-OADS,/arxiv_data1/oa_pdf/35/83/IJEM-18-443.PMC4138895.pdf
Available from: http://www.who.int/diabetes/en/ [Last  accessed on 2014 Apr 1].,Non-OADS,/arxiv_data1/oa_pdf/3f/cb/IJEM-18-445.PMC4138896.pdf
Available from:  http://censusindia.gov.in [Last accessed  on 2013 Sep 01].,OADS,/arxiv_data1/oa_pdf/3f/f8/IJEM-18-449.PMC4138897.pdf
Available from: http://www.tradingeconomics.,Non-OADS,/arxiv_data1/oa_pdf/3f/f8/IJEM-18-449.PMC4138897.pdf
Available from: http://www.psychiatryonline.com/content.,Non-OADS,/arxiv_data1/oa_pdf/58/43/IJEM-18-468.PMC4138899.pdf
"Available from: http://www.idf.org/webdata/ docs/Guideline_PMG_final.pdf [Last accessed on  2014 Jan 20].Table 5: Baseline and 24‑week data for blood lipids,  body weight and SBP Basal‑bolus  insulinNPH  insulinInsulin  glargine Total cholesterol, mmol/L n - 40 87 Baseline 5.5±0.7 5.1±1.0 Week 24 5.1±0.6 4.8±0.9 Change −0.4±0.2 −0.4±0.4 Triglycerides, mmol/L n 18 56 99 Baseline 2.2±1.1 2.1±0.4 2.1±0.7 Week 24 1.7±0.6 1.9±0.4 1.9±0.6 Change −0.5±0.9 −0.2±0.2 −0.2±0.3 HDL cholesterol, mmol/L n 17 54 97 Baseline 1.1±0.2 1.1±0.2 1.0±0.2 Week 24 1.1±0.2 1.0±0.2 1.0±0.2 Change −0.0±0.2 −0.0±0.2 −0.1±0.2 LDL cholesterol, mmol/L n 17 54 97 Baseline 3.2±1.1 3.2±0.6 3.0±0.8 Week 24 2.6±0.5 2.8±0.6 2.8±0.7 Change −0.6±1.0 −0.4±0.4 −0.3±0.5 Body weight, kg n 34 122 188 Baseline 69.6±12.5 67 .8±11.6 71.5±11.1 Week 24 70.2±11.8 68.8±10.4 70.8±10.4 Change 0.6±2.2 1.0±5.6 −0.6±3.8 P − 0.052 0.021 SBP, mmHg n 35 81 159 Baseline 136.3±14.4 141.7±14.5 131.9±18.1 Week 24 126.4±10.4 131.4±10.4 125.7±11.1 Change −9.9±11.5 −10.3±10.2 −6.2±13.4 P - - <0.001 HDL: High -density lipoprotein, LDL: Low- density lipoprotein, SBP: Systolic blood  pressure.",Non-OADS,/arxiv_data1/oa_pdf/d9/3f/IJEM-18-480.PMC4138901.pdf
Available from: http://www.idf.org/webdata/docs/idf_meta_def_final.,Non-OADS,/arxiv_data1/oa_pdf/da/3d/IJEM-18-496.PMC4138904.pdf
Hot Thyroidology (http://www.hotthyroidology.com; Online  ISSN: 2075‑2202) 2002; No.,Non-OADS,/arxiv_data1/oa_pdf/32/7f/IJEM-18-526.PMC4138910.pdf
Available from:  http://www.stats.gov.nl.ca/Statistics/Census2001/PDF/POP_ Can‑Provs‑Terrs_2001.PDF .,OADS,/arxiv_data1/oa_pdf/04/5b/IJEM-18-542.PMC4138913.pdf
Available  from: https://www.aace.com/files/hypo‑gonadism.pdf ‑United  States.,Non-OADS,/arxiv_data1/oa_pdf/0c/33/IJEM-18-558.PMC4138916.pdf
"Please refer the below link to view complete figure  11a-c and d: http://www.ijem.in/article.asp?issn=2230-8210;year=2014;volume=18;issue=3;spage=295;epage=303;  aulast=Panda The error is regretted - Editor, IJEM",Non-OADS,/arxiv_data1/oa_pdf/4f/93/IJEM-18-574.PMC4138919.pdf
"Please refer the below link to view complete figure  11a-c and d: http://www.ijem.in/article.asp?issn=2230-8210;year=2014;volume=18;issue=3;spage=295;epage=303;  aulast=Panda The error is regretted - Editor, IJEM",Non-OADS,/arxiv_data1/oa_pdf/26/3b/IJEM-18-581.PMC4138920.pdf
Available from: http://www.un.org/ga/search/view_doc.,Non-OADS,/arxiv_data1/oa_pdf/2c/4c/IJEM-18-588.PMC4138924.pdf
"Geneva: World Health Association, May 26,  2012 Available from: http://www.who.int/mediacentre/news/ releases/2012/wha65_closes_20120526/en/index.html [Last    accessed on 2014 Apr 20].6.",Non-OADS,/arxiv_data1/oa_pdf/2c/4c/IJEM-18-588.PMC4138924.pdf
Available from: http://www.un.org/ga/search/view_doc.,Non-OADS,/arxiv_data1/oa_pdf/71/df/IJEM-18-589.PMC4138925.pdf
"Geneva: World Health Association, May 26,  2012 Available from: http://www.who.int/mediacentre/news/ releases/2012/wha65_closes_20120526/en/index.html [Last    accessed on 2014 Apr 20].6.",Non-OADS,/arxiv_data1/oa_pdf/71/df/IJEM-18-589.PMC4138925.pdf
"[*] Dr. S. Pornsuwan,[+]Prof. M. Bennati Research Group EPR SpectroscopyMax-Planck Institute for Biophysical Chemistry Am Fassberg 11, 37077 Gçttingen (Germany) E-mail: Marina.Bennati@mpibpc.mpg.de Homepage: http://www.mpibpc.mpg.de/english/research/ags/ bennati/ Prof. M. Bennati Department of Chemistry, University of Gçttingen Tammanstr.",Non-OADS,/arxiv_data1/oa_pdf/26/bb/anie0052-10290.PMC4138985.pdf
Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/anie.201304747.,Non-OADS,/arxiv_data1/oa_pdf/26/bb/anie0052-10290.PMC4138985.pdf
Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/anie.201308334.,Non-OADS,/arxiv_data1/oa_pdf/f5/2f/anie0053-1087.PMC4138987.pdf
Supporting information for this article is available on the WWWunder http://dx.doi.org/10.1002/anie.201305276.,Non-OADS,/arxiv_data1/oa_pdf/47/15/anie0052-12047.PMC4138989.pdf
Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/anie.201304914.,Non-OADS,/arxiv_data1/oa_pdf/05/88/anie0052-11401.PMC4138990.pdf
"[*] Dr. T. Sakai, D. Mersch, Dr. E. Reisner Department of Chemistry, University of Cambridge Lensfield Road, Cambridge CB2 1EW (UK) E-mail: reisner@ch.cam.ac.ukHomepage: http://www-reisner.ch.cam.ac.uk/ [**] This work was supported by the U.K. Engineering and Physical Sciences Research Council (EP/H00338X/2 to E.R.)",Non-OADS,/arxiv_data1/oa_pdf/f7/72/anie0052-12313.PMC4138992.pdf
Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/anie.201306214.,Non-OADS,/arxiv_data1/oa_pdf/f7/72/anie0052-12313.PMC4138992.pdf
"[*] E. J. Emmett, Prof. M. C. Willis Department of Chemistry, University of OxfordChemistry Research Laboratory Mansfield Road, Oxford, OX1 3TA (UK) E-mail: michael.willis@chem.ox.ac.ukHomepage: http://mcwillis.chem.ox.ac.uk/MCW/Home.html Dr. B. R. Hayter Oncology Innovative Medicines, AstraZeneca Alderley Park, Macclesfield, Cheshire, SK10 4TG (UK) [**] This work was supported by the EPSRC and AstraZeneca.",Non-OADS,/arxiv_data1/oa_pdf/b5/02/anie0052-12679.PMC4138993.pdf
Supporting information for this article is available on the WWWunder http://dx.doi.org/10.1002/anie.201305369.,Non-OADS,/arxiv_data1/oa_pdf/b5/02/anie0052-12679.PMC4138993.pdf
Supporting information for this article is available on the WWWunder http://dx.doi.org/10.1002/anie.201308778.,Non-OADS,/arxiv_data1/oa_pdf/d3/1a/anie0053-1598.PMC4138996.pdf
"[*] S. Shibata, Dr. T. Suenobu, Prof. Dr. S. Fukuzumi Department of Material and Life Science Graduate School of Engineering, Osaka University 2-1 Yamada-oka, Suita, Osaka 565-0871 (Japan)E-mail: fukuzumi@chem.eng.osaka-u.ac.jp Homepage: http://www-etchem.mls.eng.osaka-u.ac.jp/ Prof. Dr. S. Fukuzumi Department of Bioinspired Science, Ewha Womans UniversitySeoul 120-750 (Korea) [**] This work was supported by Grants-in-Aid (Nos.",Non-OADS,/arxiv_data1/oa_pdf/07/88/anie0052-12327.PMC4138997.pdf
Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/anie.201307273.,Non-OADS,/arxiv_data1/oa_pdf/07/88/anie0052-12327.PMC4138997.pdf
Supporting information for this article is available on the WWWunder http://dx.doi.org/10.1002/anie.201307950.,Non-OADS,/arxiv_data1/oa_pdf/b2/ec/anie0053-0761.PMC4138999.pdf
G eneve: World health  Organization;2004.http://www.who.int/chp/knowledge/publicat ions/adherence_report/en/index.html (accessed 1-7-2009),Non-OADS,/arxiv_data1/oa_pdf/33/ca/pharmpract-07-125.PMC4139043.pdf
https://www.educacion.es/ructweb /jsp/busquedaDo.do?opcionMenu=BusquedaSimpl e&codTipoUniversidad=T&nomTip oUniversidad=Todas&codUnive rsidad=T&nomUniversidad=Todas&nomTitula =Grado%20en%20Farmacia&codRama=4 31005&nomRama=Ciencias%20de%20la%20Sa lud&codAut=00&codProv=00&tipo Ensenanza=CICLO (accessed 1-7- 2009).,Non-OADS,/arxiv_data1/oa_pdf/33/ca/pharmpract-07-125.PMC4139043.pdf
2004. http://bscw.iesalbasit.es/pub/bscw.c gi/d102154/PLAN%20ESTRATICO%20DE%20SANIDAD.pdf  (accessed 1-7-2009).,Non-OADS,/arxiv_data1/oa_pdf/33/ca/pharmpract-07-125.PMC4139043.pdf
[Ministerio de Sanidad y Política Soci al - Gabinete de Prensa - Notas de Prensa]:  http://www.msps.es/gabinetePrensa/notaPrensa/ de sarrolloNotaPrensa.jsp?id=1443 (accessed 1-7-2009).,Non-OADS,/arxiv_data1/oa_pdf/33/ca/pharmpract-07-125.PMC4139043.pdf
Available from:  http://www.who.int/reproductive-heal th/publications/mec/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/ff/db/pharmpract-07-139.PMC4139044.pdf
Available from: http://online.lexi.com.,Non-OADS,/arxiv_data1/oa_pdf/ff/db/pharmpract-07-139.PMC4139044.pdf
Available from: http://cp.gsm.com.,Non-OADS,/arxiv_data1/oa_pdf/ff/db/pharmpract-07-139.PMC4139044.pdf
[Cited 2008 Nov 13] Available from: URL:  http://www.samford.edu/schools/pharmacy/ijpe/106/oparah.pdf  11.,Non-OADS,/arxiv_data1/oa_pdf/b1/c8/pharmpract-07-145.PMC4139045.pdf
[Cited 2008 Oct 3] Available from: URL:  http://www.socialresearchmethods.net/kb/scallik.php  13.,Non-OADS,/arxiv_data1/oa_pdf/b1/c8/pharmpract-07-145.PMC4139045.pdf
"Cancer Facts and Figures 2006.  http://www.cancer.org/downloads/STT/CAFF2006P WSecured.pdf (accessed on March 10, 2009).",OADS,/arxiv_data1/oa_pdf/a4/b5/pharmpract-07-150.PMC4139046.pdf
Diabetes Prevalence 2005. http://www.idf.org/home/index.cfm?,Non-OADS,/arxiv_data1/oa_pdf/3d/ee/pharmpract-07-163.PMC4139048.pdf
http://statdirect.com/  30.,Non-OADS,/arxiv_data1/oa_pdf/3d/ee/pharmpract-07-163.PMC4139048.pdf
http://www.cdc.gov/epiinfo/  31.,Non-OADS,/arxiv_data1/oa_pdf/3d/ee/pharmpract-07-163.PMC4139048.pdf
"http://www.gelbe- liste.de/pharmindex/identa/suche/ (accessed June 26, 2009)  12.",Non-OADS,/arxiv_data1/oa_pdf/6d/4c/pharmpract-07-170.PMC4139049.pdf
"QRD Template centralised procedure ve rsion 7.2 and MR/DC/referral procedures 1.2.  http://www.emea.europa.eu/htms/human/qrd/qrdtemplate.htm (accessed March 9, 2009)",Non-OADS,/arxiv_data1/oa_pdf/6d/4c/pharmpract-07-170.PMC4139049.pdf
"Available from http://www.sci osinc.com/scios/press/2005 (accessed April 11, 2007).",Non-OADS,/arxiv_data1/oa_pdf/23/eb/pharmpract-07-175.PMC4139050.pdf
"Available from http://www.sciosinc.com/ scios/press/2005 (accessed April 11, 2007).",Non-OADS,/arxiv_data1/oa_pdf/23/eb/pharmpract-07-175.PMC4139050.pdf
"American Pharmacists Association, Medication Therapy Management (MTM), 2009,  http://www.pharmacist.com/AM/Template .cfm?section=MTM (accessed on June 2009)  7.",Non-OADS,/arxiv_data1/oa_pdf/d6/fa/pharmpract-07-181.PMC4139051.pdf
"Distinctive from *Correspondence to: Cheston B Cunha; Email: ccunha@lifespan.org Submitted: 07/16/2014; Accepted: 07/19/2014; Published Online: 08/04/2014 http://dx.doi.org/10.4161/viru.32077Middle East respiratory syndrome (MERS) A new zoonotic viral pneumonia Cheston B Cunha1,2,* and Steven M Opal2,3 1Division of Infectious Disease; Rhode Island Hospital and The Miriam Hospital; Providence, RI USA; 2Division of Infectious Disease; Brown University Alpert School of Medicine;  Providence, RI USA; 3Division of Infectious Disease; Memorial Hospital; Pawtucket, RI USA Keywords:  MERS, Middle Eastern respiratory syndrome, coronavirus, emerging pathogens Coronaviruses have traditionally been associated with mild  upper respiratory tract infections throughout the world.",Non-OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
J Virol 2014;  88:5209-12;  PMID:24600003 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Curr Opin Virol 2014; 5:58-62; PMID:24584035 ;  http://dx.doi.org/10.1016/j.coviro.2014.01.010 5.,OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Euro Surveill 2014; 19:20781;  PMID:24786259 ; http://dx.doi.org/10.2807/1560- 7917.ES2014.19.16.20781 6.,Non-OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Curr Opin Pulm Med 2014; 20:233- 41; PMID:24626235 ; http://dx.doi.org/10.1097/ MCP.0000000000000046 7.,OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Curr Infect Dis Rep 2013; 15:295- 8; PMID:23793899 ; http://dx.doi.org/10.1007/ s11908-013-0344-2 8.,OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Lancet Infect Dis 2013; 13:752- 61; PMID:23891402 ; http://dx.doi.org/10.1016/ S1473-3099(13)70204-4 9.,Non-OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Eur Respir J 2014;  43:1243-8;  PMID:24627533 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Lancet 2013; 382:694-9;  PMID:23831141 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Infect Dis Clin North Am 2004; 18:141-55;  PMID :15081510 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Infect Dis Clin North Am 2010; 24:203-28;  PMID:20171553 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
N Engl J Med 2013; 368:2277-85; PMID:23697469 ; http://dx.doi.org/10.1056/ NEJMoa1305584 17.,OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Ann Intern Med 2014; 160:389- 97; PMID:24474051 ; http://dx.doi.org/10.7326/ M13-2486 18.,Non-OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Lancet Infect Dis  2013; 13:745-51;  PMID:23782859 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Int J Infect Dis 2013; 17:e668-72; PMID:23916548 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Int J Infect Dis 2013; 17:e792- 8; PMID:23993766 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Int J Infect Dis  2014; 20:42-6;  PMID:24406736 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
N Engl J Med  2013; 369:407-16;  PMID:23782161 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
N Engl J Med 2013; 369:1761-2; PMID:24171524 ; http://dx.doi.org/10.1056/ NEJMc1308698 25.,Non-OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Int J Infect Dis 2014; 20:77-8; PMID:24355682 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
N Engl J Med 2013; 369:884- 6; PMID:23923992 ; http://dx.doi.org/10.1056/ NEJMc1308698 27.,Non-OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Lancet 2013;  381:2265-72;  PMID:23727167 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Int J Infect  Dis 2014; 23:63-8; PMID:24699184 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
Int J Antimicrob Agents 2010; 35:200- 1; PMID:20005682 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b6/15/viru-5-650.PMC4139405.pdf
"*Correspondence to: Tianhua Yan; Email: 13016931191@126.com;   Yongbing Cao; Email: ybcao@vip.sina.comSubmitted: 12/09/2013; Revised: 07/25/2014; Accepted: 07/28/2014;  Published Online: 08/07/2014 http://dx.doi.org/10.4161/viru.32180The structure and retrotransposition mechanism  of LTR-retrotransposons in the asexual yeast  Candida albicans Lulu Zhang1,†, Lan Yan1,†, Jingchen Jiang2, Yan w ang1, Yuanying Jiang1, Tianhua Yan2,*, and Yongbing Cao1,* 1Research and Develop Center of New Drug; School of Pharmacy; Second Military Medical University; Shanghai, PR China; 2Department of Pharmacology; School of Pharmacy;  China Pharmaceutical University; Nanjing, PR China †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
J Am  Acad Dermatol 1994; 31:S2-5; PMID:8077502 ;  http://dx.doi.org/10.1016/S0190-9622(08)81257-1 2.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Adv Appl  Microbiol  2003 ; 53:271-90; PMID:14696322 ;  http://dx.doi.org/10.1016/S0065-2164(03)53008-8 3.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Nature  2001 ;  409:847-9; PMID:11237007 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Genetica   1997 ; 100:185-95; PMID:9440272 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Nature  2001 ;  409:860-921; PMID:11237011 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Nat Genet 1998 ; 20:43-5;  PMID :9731528 ; http://dx.doi.org/10.1038/1695 10.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
J Basic Microbiol 2013 ;  Forthcoming ; PMID:23440766 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Virus Res 2008 ; 134:221- 34; PMID:18261821 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Genome Res 2002 ; 12:930-43; PMID:12045146 ;  http://dx.doi.org/10.1101/gr.21920214.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
PLoS One  2012 ; 7:e50978 ;  PMID:23226439 ; http://dx.doi.org/10.1371/ journal.pone.0050978 15.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Genome Res 2000 ; 10:174- 91; PMID:10673276 ; http://dx.doi.org/10.1101/ gr.10.2.174 16.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Oncogene  2005 ; 24:7656 -72; PMID:16299527 ;  http://dx.doi.org/10.1038/sj.onc.1209043 19.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Yeast   2000 ; 16:1509 -18; PMID:11113973 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Nucleic Acids Res 1996 ; 24:4825 - 31; PMID:8972872 ; http://dx.doi.org/10.1093/ nar/24.23.4825 24.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Curr Biol  2012 ;  22:R432 -7; PMID:22677280 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Nucleic Acids Res  1988 ; 16:1829 -36; PMID:2832831 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Nucleic Acids Res 1994 ; 22:5156 - 63; PMID:7816600 ; http://dx.doi.org/10.1093/ nar/22.24.5156 32.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Microb Pathog   1989 ; 7:1-10; PMID:2682128 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Mol Cell Biol  2001 ;  21:6606 -14; PMID:11533248 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Genes Dev 1999 ; 13:2738 -49; PMID :10541559 ;  http://dx.doi.org/10.1101/gad.13.20.273838.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Genes Dev 1996 ; 10:634-45; PMID:8598292 ;  http://dx.doi.org/10.1101/gad.10.5.634 39.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Proc Natl Acad Sci U S  A 1995 ; 92:920-4; PMID:7846079 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Proc Natl Acad Sci U S  A 1985 ; 82:1618 -22; PMID :3885215 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
BMC Mol Biol  2007 ; 8:94; PMID:17961216 ;  http://dx.doi.org/10.1186/1471-2199-8-94 42.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Biochemistry  1992 ;  31:11665 -76; PMID:1280160 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Mol Gen Genet  1984 ; 198:179-82; PMID:6394964 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Proc Natl Acad Sci U S  A 1996 ; 93:12473 -7; PMID:8901606 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Gene  1992 ;  122:119-28; PMID:1333437 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
J Med Vet Mycol 1986 ; 24:407-13; PMID:3537262 ;  http://dx.doi.org/10.1080/0268121868000062152.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Mycopathol Mycol Appl  1969 ;  37:345-8; PMID:5797623 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Curr Biol  1996 ; 6:959-61;  PMID:8805314 ; http://dx.doi.org/10.1016/ S0960-9822(02)00638-3 61.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Mol Cell Biol  2008 ; 28:5543 - 54; PMID:18591253 ; http://dx.doi.org/10.1128/ MCB.00416-08 62.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Genetics  2007 ; 176:815-27;  PMID:17435252 ; http://dx.doi.org/10.1534/ genetics.107.071647 63.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
J Biol Chem 2001 ; 276:1896 -903;  PMID :11054415 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
Trends Genet   2003 ; 19:530-6; PMID:14550626 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9f/2c/viru-5-655.PMC4139406.pdf
"I think this statement by my grand - father in the 1960s pushed my mother to Virulence profile Kerry L LaPlante Kerry L LaPlante1,2 1College of Pharmacy; University of Rhode Island; Kingston, RI USA; 2Departments of Pharmacy and Research; Providence Veterans Affairs Medical Center;  Providence, RI USA Keywords:  host–pathogen  interactions, drug–drug interactions, pharmacodynamics Correspondence to: Kerry L LaPlante;   Email: KerryLaPlante@uri.edu Submitted: 07/10/2014Accepte d: 07/11/2014Published Online: 08/04/2014http://dx.doi.org/10.4161/viru.32401",Non-OADS,/arxiv_data1/oa_pdf/79/46/viru-5-691.PMC4139410.pdf
"Twelve altered proteins were identified in their study, including the proteins involved in cell regulations and processes such as antioxidative defense, differentiation, cell  Received: September 9, 2013 Accepted: January 29, 2014Published online in J-STAGE: March 11, 2014©2014 by the Society for Reproduction and DevelopmentCorrespondence: E Kamali-Sarvestani (e-mail: immunol2@sums.ac.ir) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/8c/55/jrd-60-261.PMC4139499.pdf
The MASCOT program search algorithm (http://www.matrixscience.com) was used to search the National Center for Biotechnology Information database (NCBI:  http://www.ncbi.nlm.nih.gov).,OADS,/arxiv_data1/oa_pdf/8c/55/jrd-60-261.PMC4139499.pdf
"It is known that glycosaminoglycans, including hyaluronan  (hyaluronic acid: HA), are synthesized in cumulus cells in the  response to stimulation with FSH and LH [16, 17] and that HA is  Received: October 18, 2013 Accepted: March 20, 2014Published online in J-STAGE: April 21, 2014©2014 by the Society for Reproduction and DevelopmentCorrespondence: M Hosoe (e-mail: hosoe@affrc.go.jp) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/eb/5f/jrd-60-268.PMC4139500.pdf
"In general, it is readily converted to 25-hydroxyvitamin D 3 (25(OH) D), a pro-active form of vitamin D, by a hepatic enzyme cytochrome Received: February 3, 2014 Accepted: March 27, 2014Published online in J-STAGE: April 25, 2014©2014 by the Society for Reproduction and DevelopmentCorrespondence: M Matsuda (e-mail: matsudam@md.tsukuba.ac.jp) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/dc/9e/jrd-60-274.PMC4139501.pdf
"Therefore, we hypothesized LPS may suppress P4 and A4 production of bovine  Received: November 16, 2013 Accepted: March 29, 2014Published online in J-STAGE: April 25, 2014©2014 by the Society for Reproduction and DevelopmentCorrespondence: T Shimizu (e-mail: shimizut@obihiro.ac.jp) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/30/1d/jrd-60-280.PMC4139502.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/14/50/jrd-60-288.PMC4139503.pdf
"Tpit/E cells have a phenotype  Received: March 12, 2014 Accepted: April 14, 2014Published online in J-STAGE: June 2, 2014©2014 by the Society for Reproduction and DevelopmentCorrespondence: Y Kato (e-mail: yukato@isc.meiji.ac.jp) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/5f/68/jrd-60-295.PMC4139504.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/7b/d4/jrd-60-304.PMC4139505.pdf
"Received: November 26, 2013 Accepted: April 15, 2014Published online in J-STAGE: June 6, 2014©2014 by the Society for Reproduction and DevelopmentCorrespondence: H Tsukamura (e-mail: htsukamura@nagoya-u.jp) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/3f/23/jrd-60-312.PMC4139506.pdf
"Materials and Methods Ethics statement This study was carried out in accordance with the Regulation on  Animal Experimentation at Kyoto University.Received: November 25, 2013 Accepted: April 23, 2014Published online in J-STAGE: June 3, 2014©2014 by the Society for Reproduction and DevelopmentCorrespondence: S Ikeda (e-mail: ikedash@kais.kyoto-u.ac.jp) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/f2/4c/jrd-60-317.PMC4139507.pdf
"1:  Received: December 12, 2013 Accepted: March 26, 2014Published online in J-STAGE: May 4, 2014©2014 by the Society for Reproduction and DevelopmentCorrespondence: W Fujii (e-mail: awtrfj@mail.ecc.u-tokyo.ac.jp),  K Naito (e-mail: aknaito@mail.ecc.u-tokyo.ac.jp) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/74/d3/jrd-60-324.PMC4139508.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005598).,Non-OADS,/arxiv_data1/oa_pdf/5d/11/bmjopen-2014-005598.PMC4139621.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-004920).,Non-OADS,/arxiv_data1/oa_pdf/f5/0a/bmjopen-2014-004920.PMC4139622.pdf
"Trail registration number: Our protocol is registered on PROSPERO (CRD42013006476), http://www.crd.your.ac.uk/PROSPERO.BACKGROUND Essential hypertension continues to be an important public health challenge world-wide.",Non-OADS,/arxiv_data1/oa_pdf/f5/0a/bmjopen-2014-004920.PMC4139622.pdf
The following items will be assessed (http://www.cochrane-handbook.org):random sequence generation (selection bias); allocation concealment (selection bias); blinding (performance bias and detection bias); incomplete outcome data(attrition bias); selective outcome reporting (reporting bias).,Non-OADS,/arxiv_data1/oa_pdf/f5/0a/bmjopen-2014-004920.PMC4139622.pdf
Analyses will be performed with R project 3.02 (http://www.r-project.org).,Non-OADS,/arxiv_data1/oa_pdf/f5/0a/bmjopen-2014-004920.PMC4139622.pdf
http://www.whocc.no/atcddd/ (accessed Feb 2012).,OADS,/arxiv_data1/oa_pdf/7e/74/bmjopen-2014-005581.PMC4139623.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005608).,Non-OADS,/arxiv_data1/oa_pdf/ec/84/bmjopen-2014-005608.PMC4139624.pdf
"CLAHRC(Collaboration for Leadership in Applied Health Research and Care).London: Imperial College Healthcare NHS Trust, 9 November 2012.http://patientsafety.health.org.uk/resources/improving-prescribing-elderly-impe-project and.",Non-OADS,/arxiv_data1/oa_pdf/ec/84/bmjopen-2014-005608.PMC4139624.pdf
http://www.hsj.co.uk/resource-centre/best-practice/patient-involvement-resources/passport-to-improved-patient-experience/5047524.article#.UufCTNJFBpg 2.,Non-OADS,/arxiv_data1/oa_pdf/ec/84/bmjopen-2014-005608.PMC4139624.pdf
"January 2009. http://www.nice.org.uk, Clinical GuidelineNo.",Non-OADS,/arxiv_data1/oa_pdf/ec/84/bmjopen-2014-005608.PMC4139624.pdf
January 2003. http://www.who.int/medicinedocs/en/d/Js4883e 6.,OADS,/arxiv_data1/oa_pdf/ec/84/bmjopen-2014-005608.PMC4139624.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-004903).,Non-OADS,/arxiv_data1/oa_pdf/70/06/bmjopen-2014-004903.PMC4139625.pdf
29Further details about the mentalisation- based treatment is available elsewhere (http://ctu.dk/publications/supplementary-material.aspx).,Non-OADS,/arxiv_data1/oa_pdf/70/06/bmjopen-2014-004903.PMC4139625.pdf
40–44(2) Both of the trial interventions were conducted using manuals (availableat http://ctu.dk/publications/supplementary-material.,Non-OADS,/arxiv_data1/oa_pdf/70/06/bmjopen-2014-004903.PMC4139625.pdf
"Mentalisation-based treatment We did not ﬁnd any relevant treatment manual we could use for the mentalisation-based treatment, and we there-fore created our own manual (http://ctu.dk/ publications/supplementary-material.aspx).",Non-OADS,/arxiv_data1/oa_pdf/70/06/bmjopen-2014-004903.PMC4139625.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.2d7h5.,OADS,/arxiv_data1/oa_pdf/70/06/bmjopen-2014-004903.PMC4139625.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/70/06/bmjopen-2014-004903.PMC4139625.pdf
Saxo.com (2011) 2011. http://www.saxo.com/dk/manual-for-mentaliseringsbasert-psykedukativ-gruppeterapi-mbt-i_sigmund-karterud_haeftet_9788205419674 17.,Non-OADS,/arxiv_data1/oa_pdf/70/06/bmjopen-2014-004903.PMC4139625.pdf
http://www.ctu.dk 2010.,Non-OADS,/arxiv_data1/oa_pdf/70/06/bmjopen-2014-004903.PMC4139625.pdf
2009. http://www.ctu.dk 30.,Non-OADS,/arxiv_data1/oa_pdf/70/06/bmjopen-2014-004903.PMC4139625.pdf
http://www.ctu.dk/tsa 38.,Non-OADS,/arxiv_data1/oa_pdf/70/06/bmjopen-2014-004903.PMC4139625.pdf
2011. http://www.cochrane-handbook.org 45.,OADS,/arxiv_data1/oa_pdf/70/06/bmjopen-2014-004903.PMC4139625.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005482).,Non-OADS,/arxiv_data1/oa_pdf/4b/d6/bmjopen-2014-005482.PMC4139626.pdf
2012. http://www.oshpd.ca.gov/HID/ Products/Hospitals/Chrgmstr/index.html (accessed 10 Dec 2013).,OADS,/arxiv_data1/oa_pdf/4b/d6/bmjopen-2014-005482.PMC4139626.pdf
"US Department of Health and Human Services, 2011. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Historical-Impact-Files-for-FY-1994-through-Present.html (accessed14 Apr 2014).",Non-OADS,/arxiv_data1/oa_pdf/4b/d6/bmjopen-2014-005482.PMC4139626.pdf
The National Review Online 28 February 2013. http://www.nationalreview.com/agenda/341951/guest-post-oren-cass-what-steven-brill-gets-wrong-us-health-care-costs-reihan-salam (accessed 17 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/4b/d6/bmjopen-2014-005482.PMC4139626.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005230).,Non-OADS,/arxiv_data1/oa_pdf/a2/28/bmjopen-2014-005230.PMC4139627.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a2/28/bmjopen-2014-005230.PMC4139627.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005615).,Non-OADS,/arxiv_data1/oa_pdf/ee/f4/bmjopen-2014-005615.PMC4139628.pdf
2012. http://www.ryumachi-jp.com/info/TNF_chart.html [Japanese].,OADS,/arxiv_data1/oa_pdf/ee/f4/bmjopen-2014-005615.PMC4139628.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006005).,Non-OADS,/arxiv_data1/oa_pdf/0b/3f/bmjopen-2014-006005.PMC4139630.pdf
http://www.actmalaria.net/files/vector_control/ (accessed 15 Jul 2012).,OADS,/arxiv_data1/oa_pdf/0b/3f/bmjopen-2014-006005.PMC4139630.pdf
2013. http://apmen.org/ storage/apmen-v/apmen-v-powerpoint-presentations-all/day-1/APMENV_S6_Artesunate-mefloquine%20vs.%20chloroquine%20in%20patients%20with%20P.vivax%20-%20a%20randomized%20open%20label%20trial%20Sabah_Tim%20William1.pdf (accessed4 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/0b/3f/bmjopen-2014-006005.PMC4139630.pdf
http://www.ich.org/products/ guidelines/efficacy/efficacy-single/article/good-clinical-practice.html 60.,Non-OADS,/arxiv_data1/oa_pdf/0b/3f/bmjopen-2014-006005.PMC4139630.pdf
"This device is validated and has been used in other studies with primary and high school children (see eg, http://www.iconnect.co.uk and http://www.cedar.iph.cam.ac.uk/research/directory/speedy/).",Non-OADS,/arxiv_data1/oa_pdf/04/b9/bmjopen-2014-005729.PMC4139631.pdf
"These tests have been extensively used in previous cohort studies of young people (eg, http://www.chasestudy.ac.uk/study- measurement) and have shown good validity and reliabil-ity in young people across broad age groups (http:// www.chasestudy.ac.uk/study-measurement).",Non-OADS,/arxiv_data1/oa_pdf/04/b9/bmjopen-2014-005729.PMC4139631.pdf
The question-naire also includes items on travel mode (as used in the iConnect Study; http://www.iconnect.co.uk).,Non-OADS,/arxiv_data1/oa_pdf/04/b9/bmjopen-2014-005729.PMC4139631.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005751).,Non-OADS,/arxiv_data1/oa_pdf/5a/51/bmjopen-2014-005751.PMC4139632.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. WHO.,Non-OADS,/arxiv_data1/oa_pdf/5a/51/bmjopen-2014-005751.PMC4139632.pdf
[Web Pages] 20 Nov. 2013.http://www2.warwick.ac.uk/fac/med/about/global/etatmba/about/ 21.,Non-OADS,/arxiv_data1/oa_pdf/5a/51/bmjopen-2014-005751.PMC4139632.pdf
2013. http://www.health.org.uk/publications/maikhanda/ (accessed 09/07/2014).,Non-OADS,/arxiv_data1/oa_pdf/5a/51/bmjopen-2014-005751.PMC4139632.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-005734).,Non-OADS,/arxiv_data1/oa_pdf/4e/8f/bmjopen-2014-005734.PMC4139633.pdf
"Ferney-Voltaire: WMA, 2008. http://www.wma.net/en/30publications/10policies/b3/index.html 3. International Conference on Harmonisation (ICH).",Non-OADS,/arxiv_data1/oa_pdf/4e/8f/bmjopen-2014-005734.PMC4139633.pdf
25. http://healthtalkonline.org/peoples-experiences/medical-research/ clinical-trials/topics 26. http://www.nih.gov/health/clinicaltrials/stories/index.htm27.,Non-OADS,/arxiv_data1/oa_pdf/4e/8f/bmjopen-2014-005734.PMC4139633.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-005051).,Non-OADS,/arxiv_data1/oa_pdf/21/2a/bmjopen-2014-005051.PMC4139634.pdf
"London, UK: Food Standards Agency, 2006. http://www.food.gov.uk/multimedia/pdfs/salttargetsapril06.pdf (accessed 29 Jul 2013).Table 4 Percentage of supermarket and branded products that meet the 2012 targets Cheese type 2012 salt target (g/100 g)Meeting target N Supermarket (%) N Branded (%) Cheddar/cheddar style 1.8 168 90 46 73 Other processed 2.0 5 36 7 88Cheese spread 2.25 7 100 12 100Cheshire 1.8 8 100 0 naCottage cheese 0.63 14 93 0 naCream cheese 0.75 12 86 2 40Double Gloucester 1.8 6 100 0 naRed Leicester 1.8 17 85 1 100Blue cheese 2.1 12 92 2 100Wensleydale 1.8 13 100 1 100 6 Hashem KM, et al.BMJ Open 2014; 4:e005051.",Non-OADS,/arxiv_data1/oa_pdf/21/2a/bmjopen-2014-005051.PMC4139634.pdf
2009. http://www.food.gov.uk/news/newsarchive/2009/may/ salttargets (accessed 29 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/21/2a/bmjopen-2014-005051.PMC4139634.pdf
"Department of Health: Assessment of dietary sodium levels among adults (aged 19-64) in England, 2011. http://transparency.dh.gov.uk/2012/06/21/sodium-levels-among-adults/ (accessed 29 Jul 2013).",Non-OADS,/arxiv_data1/oa_pdf/21/2a/bmjopen-2014-005051.PMC4139634.pdf
Guidance on the prevention of cardiovascular disease at the population level.http://guidance.nice.org.uk/PH25 (accessed 26 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/21/2a/bmjopen-2014-005051.PMC4139634.pdf
http://www.dairyco.org.uk/market-information/processing- trade/dairy-product-production/uk-dairy-product-production/ 23.,Non-OADS,/arxiv_data1/oa_pdf/21/2a/bmjopen-2014-005051.PMC4139634.pdf
"Wellington: Ministry of Health, 2003. http://www.moh.govt.nz/notebook/nbbooks.nsf/0/A8D85BC5BAD17610CC256D970072A0AA/$file/ 28.",Non-OADS,/arxiv_data1/oa_pdf/21/2a/bmjopen-2014-005051.PMC4139634.pdf
http://www.statcan.gc.,OADS,/arxiv_data1/oa_pdf/21/2a/bmjopen-2014-005051.PMC4139634.pdf
http://www.nyc.gov/html/doh/downloads/pdf/cardio/packaged-food-targets.pdf (accessed 28 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/21/2a/bmjopen-2014-005051.PMC4139634.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005181).,Non-OADS,/arxiv_data1/oa_pdf/ba/0e/bmjopen-2014-005181.PMC4139635.pdf
http://www.acc.org/clinical/guidelines/failure//index.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/ba/0e/bmjopen-2014-005181.PMC4139635.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004751).,Non-OADS,/arxiv_data1/oa_pdf/44/d8/bmjopen-2013-004751.PMC4139636.pdf
(http://www.nestlefoundation.org/ e/docs/AnnualReport2004.pdf) Competing interests None.,Non-OADS,/arxiv_data1/oa_pdf/44/d8/bmjopen-2013-004751.PMC4139636.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005438).,Non-OADS,/arxiv_data1/oa_pdf/d9/89/bmjopen-2014-005438.PMC4139637.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d9/89/bmjopen-2014-005438.PMC4139637.pdf
The CochraneCollaboration 2011. http://www.cochrane-handbook.org (accessedJun 2014).,OADS,/arxiv_data1/oa_pdf/ed/d1/bmjopen-2014-005896.PMC4139638.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005556).,Non-OADS,/arxiv_data1/oa_pdf/c4/8a/bmjopen-2014-005556.PMC4139639.pdf
http://www.iprc.unc.edu/sportsinjurystatistics.shtml(accessed 10 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/c4/8a/bmjopen-2014-005556.PMC4139639.pdf
http://www.sarugby.co.,Non-OADS,/arxiv_data1/oa_pdf/c4/8a/bmjopen-2014-005556.PMC4139639.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005385).,Non-OADS,/arxiv_data1/oa_pdf/99/06/bmjopen-2014-005385.PMC4139640.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.16h8j.,OADS,/arxiv_data1/oa_pdf/99/06/bmjopen-2014-005385.PMC4139640.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/99/06/bmjopen-2014-005385.PMC4139640.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005493).,Non-OADS,/arxiv_data1/oa_pdf/7e/8a/bmjopen-2014-005493.PMC4139641.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7e/8a/bmjopen-2014-005493.PMC4139641.pdf
J Gen Pract 2013;1:2. http://dx.doi.org/10.4172/2329 – 9126.1000e103.,Non-OADS,/arxiv_data1/oa_pdf/7e/8a/bmjopen-2014-005493.PMC4139641.pdf
BMC Med Res Method 2013;13:14. http://www.biomedcentral.com/1471-2288/13/14 36.,Non-OADS,/arxiv_data1/oa_pdf/7e/8a/bmjopen-2014-005493.PMC4139641.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5a/b8/bmjopen-2014-005900.PMC4139642.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 005785).,Non-OADS,/arxiv_data1/oa_pdf/ab/36/bmjopen-2014-005785.PMC4139643.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/36/bmjopen-2014-005785.PMC4139643.pdf
2013. http://www.tigrab.dk (accessed 13 Mar 2014).,Non-OADS,/arxiv_data1/oa_pdf/ab/36/bmjopen-2014-005785.PMC4139643.pdf
http://www.ssi.dk/Sundhedsdataogit/ Dataformidling/Sundhedsdata/Fodsler/Fodte%201973.aspx(accessed 7 Aug 2013).,OADS,/arxiv_data1/oa_pdf/ab/36/bmjopen-2014-005785.PMC4139643.pdf
"ACOG Practice bulletin (107), August 2009. http://www.pqcnc.org/documents/sivbdoc/sivbeb/2ACOG2009Practice Bulletin107InductionofLabor.pdf (accessed 13 Mar 2014).",OADS,/arxiv_data1/oa_pdf/ab/36/bmjopen-2014-005785.PMC4139643.pdf
National Board of Health [Hälso- och Sjukvård] 2013. http://www.socialstyrelsen.se/publikationer2013/2013-2-7 (accessed 13 Mar2014).,Non-OADS,/arxiv_data1/oa_pdf/ab/36/bmjopen-2014-005785.PMC4139643.pdf
Folkehelseinstituttet 2013. http://www.fhi.no/dokumenter/2a92108f4f.pdf (accessed 24 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/ab/36/bmjopen-2014-005785.PMC4139643.pdf
http://www.statistikbanken.dk/statbank5a/ default.asp?w=1024 (accessed 13 Mar 2014).,OADS,/arxiv_data1/oa_pdf/ab/36/bmjopen-2014-005785.PMC4139643.pdf
http://www.ahrq.gov/research/findings/evidence-based-reports/eil-evidence-report.pdf (accessed 13 Mar 2014).,OADS,/arxiv_data1/oa_pdf/ab/36/bmjopen-2014-005785.PMC4139643.pdf
doi:10.1136/bmjopen-2014- 005461 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005461).,Non-OADS,/arxiv_data1/oa_pdf/fb/83/bmjopen-2014-005461.PMC4139644.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005146).,Non-OADS,/arxiv_data1/oa_pdf/05/13/bmjopen-2014-005146.PMC4139645.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/05/13/bmjopen-2014-005146.PMC4139645.pdf
Secondary Quality Outcomes Framework 2012/13 results 2013. http://qof.hscic.gov.uk/index.asp 14.,Non-OADS,/arxiv_data1/oa_pdf/05/13/bmjopen-2014-005146.PMC4139645.pdf
"Secondary National General Practice Profiles —Leeds PCT 2013. http://www.apho.org.uk/PracProf/Profile.aspx#mod,2,pyr,2012,pat,2,par,E16000074,are,-,sid1,2000002,ind1,243 –4,sid2,2000005, ind2 44.",Non-OADS,/arxiv_data1/oa_pdf/05/13/bmjopen-2014-005146.PMC4139645.pdf
https://www.nice.org.uk/About/What-we-do/Into-practice/Into-practice-guide (accessed Aug 2014).,Non-OADS,/arxiv_data1/oa_pdf/05/13/bmjopen-2014-005146.PMC4139645.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005867).,Non-OADS,/arxiv_data1/oa_pdf/05/71/bmjopen-2014-005867.PMC4139646.pdf
"METHOD Study design, setting and participantsYoung-HUNT1, the ﬁrst wave of the adolescent part of the HUNT Study (Nord-Trøndelag Health Study) (http://www.ntnu.no/hunt/english), 31took place between 1995 and 1997.",Non-OADS,/arxiv_data1/oa_pdf/05/71/bmjopen-2014-005867.PMC4139646.pdf
Measures The Young-HUNT questionnaire includes a broad spec- trum of health-related variables relevant for this study(http://www.ntnu.edu/hunt/data/que).,Non-OADS,/arxiv_data1/oa_pdf/05/71/bmjopen-2014-005867.PMC4139646.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-005012).,Non-OADS,/arxiv_data1/oa_pdf/f4/51/bmjopen-2014-005012.PMC4139647.pdf
2000. http://factfinder.census.gov 30.,OADS,/arxiv_data1/oa_pdf/f0/7b/bmjopen-2014-005458.PMC4139648.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005906).,Non-OADS,/arxiv_data1/oa_pdf/54/11/bmjopen-2014-005906.PMC4139649.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005378).,Non-OADS,/arxiv_data1/oa_pdf/e9/6e/bmjopen-2014-005378.PMC4139650.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e9/6e/bmjopen-2014-005378.PMC4139650.pdf
http://www.fda.gov/ downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM378076.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/e9/6e/bmjopen-2014-005378.PMC4139650.pdf
http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM334550.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/e9/6e/bmjopen-2014-005378.PMC4139650.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/e9/6e/bmjopen-2014-005378.PMC4139650.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/e9/6e/bmjopen-2014-005378.PMC4139650.pdf
http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/e9/6e/bmjopen-2014-005378.PMC4139650.pdf
http://ec.europa.,Non-OADS,/arxiv_data1/oa_pdf/e9/6e/bmjopen-2014-005378.PMC4139650.pdf
http://apps.who.int/trialsearch/29.,Non-OADS,/arxiv_data1/oa_pdf/e9/6e/bmjopen-2014-005378.PMC4139650.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005227).,Non-OADS,/arxiv_data1/oa_pdf/5c/0b/bmjopen-2014-005227.PMC4139655.pdf
2013. http://data.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/5c/0b/bmjopen-2014-005227.PMC4139655.pdf
2013. http://www.amar.,Non-OADS,/arxiv_data1/oa_pdf/5c/0b/bmjopen-2014-005227.PMC4139655.pdf
http://hdr.undp.org/en/statistics/hdi/ (accessed 1 Dec 2013).,OADS,/arxiv_data1/oa_pdf/5c/0b/bmjopen-2014-005227.PMC4139655.pdf
Design: Prospective comparison of the probability of CTS as assessed by the web-based questionnaire athttp://www.carpal-tunnel.net with the results of nerveconduction studies.,Non-OADS,/arxiv_data1/oa_pdf/b5/9e/bmjopen-2014-005141.PMC4139658.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 004806).,Non-OADS,/arxiv_data1/oa_pdf/ac/e1/bmjopen-2014-004806.PMC4139659.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ac/e1/bmjopen-2014-004806.PMC4139659.pdf
"Protocol (Full-Scale Clinical Trial —Phase III) for the Diabetes Control and Complications Trial, 1987. http://www2.bsc.gwu.edu/bsc/oneproj.php?pkey=5 (accessed 5 Apr 2013).",Non-OADS,/arxiv_data1/oa_pdf/ac/e1/bmjopen-2014-004806.PMC4139659.pdf
http://www.pharmacoepi.org/meetings/27thconf/ (accessed 12 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/ac/e1/bmjopen-2014-004806.PMC4139659.pdf
http://www2.bsc.gwu.edu/bsc/docs/edicprot%282%29.pdf(accessed 12 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/ac/e1/bmjopen-2014-004806.PMC4139659.pdf
The CochraneCollaboration 2011. http://www.cochrane-handbook.org 53.,Non-OADS,/arxiv_data1/oa_pdf/ac/e1/bmjopen-2014-004806.PMC4139659.pdf
http://www.crd.york.ac.uk/Prospero/ 54. Review Manager (RevMan) [Computer program].,Non-OADS,/arxiv_data1/oa_pdf/ac/e1/bmjopen-2014-004806.PMC4139659.pdf
"The Copenhagen Trial Unit, Centre forClinical Intervention Research, 2011. http://www.ctu.dk/tsa68.",Non-OADS,/arxiv_data1/oa_pdf/ac/e1/bmjopen-2014-004806.PMC4139659.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-005178).,Non-OADS,/arxiv_data1/oa_pdf/30/b4/bmjopen-2014-005178.PMC4139660.pdf
"Received 3 March 2014 Revised 8 July 2014 Accepted 24 July 2014 ▸http://dx.doi.org/10.1136/ bmjopen-2014-005146 1Leeds Institute of Health Sciences, University of Leeds, Leeds, UK 2NHS England, Leeds, UK Correspondence to Dr Kate McLintock; k.l.mclintock@leeds.ac.ukABSTRACT Objective: To evaluate the effects of Quality and Outcomes Framework (QOF) incentivised case findingfor depression on diagnosis and treatment in targetedand non-targeted long-term conditions.",Non-OADS,/arxiv_data1/oa_pdf/30/b4/bmjopen-2014-005178.PMC4139660.pdf
2012. http://fingertips.phe.org.uk/ (accessed 6 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/30/b4/bmjopen-2014-005178.PMC4139660.pdf
2012. http://www.hscic.gov.uk/article/2021/ Website-Search?productid=4869&q=gp+numbers+2011&sort=Relevance&size=10&page=1&area=both#top (accessed 6 May 2014).§§Health and Social Care Information Centre.,Non-OADS,/arxiv_data1/oa_pdf/30/b4/bmjopen-2014-005178.PMC4139660.pdf
2011. https://indicators.ic.nhs.uk/ (accessed 6 May 2014).,Non-OADS,/arxiv_data1/oa_pdf/30/b4/bmjopen-2014-005178.PMC4139660.pdf
http://mqi.ic.nhs.uk/IndicatorDefaultView.aspx?ref=1.07.04 11.,Non-OADS,/arxiv_data1/oa_pdf/30/b4/bmjopen-2014-005178.PMC4139660.pdf
2012; http://www.hscic.gov.uk/searchcatalogue?productid=9548&q=qof+depression&sort= Relevance&size=10&page=1#top (accessed 18 Feb 2014).,OADS,/arxiv_data1/oa_pdf/30/b4/bmjopen-2014-005178.PMC4139660.pdf
"Leeds: Health Profiles, 2012. http://www.apho.org.uk/resource/view.aspx?RID=50215&SEARCH=L* (accessed 18 Feb 2014).",Non-OADS,/arxiv_data1/oa_pdf/30/b4/bmjopen-2014-005178.PMC4139660.pdf
2013. http://www.nepho.org.uk/cmhp (accessed 18 Feb2014).,Non-OADS,/arxiv_data1/oa_pdf/30/b4/bmjopen-2014-005178.PMC4139660.pdf
2012. http://www.hscic.gov.uk/ searchcatalogue?productid=9592&q=qof+depression&sort= Relevance&size=10&page=1#top (accessed 18 Feb 2014) 26.,Non-OADS,/arxiv_data1/oa_pdf/30/b4/bmjopen-2014-005178.PMC4139660.pdf
ISBN 3-900051-07-0. http://www.R-project.org/ 29.,Non-OADS,/arxiv_data1/oa_pdf/30/b4/bmjopen-2014-005178.PMC4139660.pdf
EPOC Resources 2002. http://epoc.cochrane.,OADS,/arxiv_data1/oa_pdf/30/b4/bmjopen-2014-005178.PMC4139660.pdf
2013. http://www.iapt.nhs.uk/ (accessed 18 Feb 2014).,Non-OADS,/arxiv_data1/oa_pdf/30/b4/bmjopen-2014-005178.PMC4139660.pdf
http://www.hscic.gov.uk/ article/2021/Website-Search?productid=12972& q=quality+outcomes+framework+2012 –13&sort=Relevance&size= 10&page=1&area= both#top (accessed 6 Jun 2014).,OADS,/arxiv_data1/oa_pdf/30/b4/bmjopen-2014-005178.PMC4139660.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-006116).,Non-OADS,/arxiv_data1/oa_pdf/ee/9b/bmjopen-2014-006116.PMC4139661.pdf
"ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttributionNon-CommercialLicense(http://creativecommons.org/licenses/by-nc/.0/),which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.European Heart Journal (2014) 35, 2174–2185 doi:10.1093/eurheartj/ehs269 4",Non-OADS,/arxiv_data1/oa_pdf/99/da/ehs269.PMC4139705.pdf
"ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttributionNon-CommercialLicense(http://creativecommons.org/licenses/by-nc/.0/),which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/28/ehu274.PMC4139706.pdf
"To view a copyof this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Metatranscriptomics of a cyanobacterial bloom K Penn et al 1878 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/00/8c/ismej201427a.PMC4139720.pdf
Community Ecology Package http://www.r-project.org.Vol.,Non-OADS,/arxiv_data1/oa_pdf/53/95/ismej201436a.PMC4139727.pdf
"To view a copyof this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Microbial community responses to wildfire NT a s ¸et al 1919 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/53/95/ismej201436a.PMC4139727.pdf
"To view a copyof this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Long-range electron transport in the seafloor SY Malkin et al 1854 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/cf/75/ismej201441a.PMC4139731.pdf
5. pharmActuel program:  http://www.pharmasuisse.org/fr/pharmazie_fachpu blikum/04_publikationen/pharmactuel.php?navanchor=1010013  (accessed 12-5-2009).,Non-OADS,/arxiv_data1/oa_pdf/d6/e6/pharmpract-07-063.PMC4139742.pdf
"Diploma in therapeutic education, Univ ersity of Geneva: http://www.unige.ch/formcont/difep.html (accessed 12-5-2009).",Non-OADS,/arxiv_data1/oa_pdf/d6/e6/pharmpract-07-063.PMC4139742.pdf
Available at:  http://www.express-scripts.com.,Non-OADS,/arxiv_data1/oa_pdf/b5/5d/pharmpract-07-074.PMC4139743.pdf
"Avail able at: http://www.infarmed.pt/portal/page/portal/INFARMED  (Accessed September 16, 2008).",Non-OADS,/arxiv_data1/oa_pdf/b5/5d/pharmpract-07-074.PMC4139743.pdf
"Available at: http://www.infarmed.pt/ portal/page/portal/INFARMED (Accessed January 28, 2009).",Non-OADS,/arxiv_data1/oa_pdf/b5/5d/pharmpract-07-074.PMC4139743.pdf
"Available at:  http://www.infarmed.pt/infarmed_noticias/infarm ed_noticias_01_02_2006.pdf (Accessed September 19, 2008).",Non-OADS,/arxiv_data1/oa_pdf/b5/5d/pharmpract-07-074.PMC4139743.pdf
"Health insurance coverage: ea rly release of estimates from the National Health Interview  Survey, 2006. http://www.cdc.gov/nchs/data/nhi s/earlyrelease/insur200706.pdf (accessed 2008 May).",OADS,/arxiv_data1/oa_pdf/d0/24/pharmpract-07-094.PMC4139746.pdf
The Kaiser Family  Foundation Public Opinion Survey Brief April 2008.  http://www.kff.org/kaiserpolls/upload/7773.pdf (accessed 2008 December).,Non-OADS,/arxiv_data1/oa_pdf/d0/24/pharmpract-07-094.PMC4139746.pdf
"January 28, 2005.  http://www.pharmacist.com/AM/Templa te.cfm?Section=Home2&TEMPLATE=/CM /ContentDisplay.cfm&CONTENTID=4 131 (accessed Dec 2008).",OADS,/arxiv_data1/oa_pdf/d0/24/pharmpract-07-094.PMC4139746.pdf
18. http://www.drugstore.com/ (accessed April 2008).,Non-OADS,/arxiv_data1/oa_pdf/d0/24/pharmpract-07-094.PMC4139746.pdf
"Available at:  http://www.ammonline.org/Media/Medical_Journal_A d_Overview.pdf  (Accessed October 10, 2007).",Non-OADS,/arxiv_data1/oa_pdf/f8/51/pharmpract-07-100.PMC4139747.pdf
Available at: http://accenture.te kgroup.com/article_display.,Non-OADS,/arxiv_data1/oa_pdf/f8/51/pharmpract-07-100.PMC4139747.pdf
Available at:  http://www.access.gpo.gov/uscode/title21/chapter9_.html (updated 14 September 2005).,Non-OADS,/arxiv_data1/oa_pdf/f8/51/pharmpract-07-100.PMC4139747.pdf
"Available at:  http://www.nafdacnigeria.org/drugs.html (Accessed Dec 5, 2008).",Non-OADS,/arxiv_data1/oa_pdf/f8/51/pharmpract-07-100.PMC4139747.pdf
"Avail able at: http://www.fda.gov/cder/drug/default.htm (Accessed Dec  5, 2008).",Non-OADS,/arxiv_data1/oa_pdf/f8/51/pharmpract-07-100.PMC4139747.pdf
Available at: http://www.inasp.,Non-OADS,/arxiv_data1/oa_pdf/f8/51/pharmpract-07-100.PMC4139747.pdf
"Available at:  http://www.pharmalot.com/2007/08/fda- spanks-pfizer-for-schizo-dr ug-ad/ (Accessed Dec 5, 2008).",Non-OADS,/arxiv_data1/oa_pdf/f8/51/pharmpract-07-100.PMC4139747.pdf
"Av ailable at: http://www.theage.com.au/news/Business/Ad-ban- disappoints-drug-maker-Roche/2007/08/30/ 1188067239979.html (Accessed Dec 5, 2008).",Non-OADS,/arxiv_data1/oa_pdf/f8/51/pharmpract-07-100.PMC4139747.pdf
"Available at:  http://www.medscape.com/viewarticle/538084 (Accessed Dec 5, 2008).",Non-OADS,/arxiv_data1/oa_pdf/f8/51/pharmpract-07-100.PMC4139747.pdf
[ In Bulgarian] Available at:  http://www.nsi.bg/SocialActivities/Health.htm.,Non-OADS,/arxiv_data1/oa_pdf/88/6d/pharmpract-07-108.PMC4139748.pdf
"Available at:  http://www.nhif.bg/bg/default.phtml?w=800&h=570 (accessed September 15, 2006).",Non-OADS,/arxiv_data1/oa_pdf/88/6d/pharmpract-07-108.PMC4139748.pdf
11. http://www.heartstats.org/datapage.asp?id=4 541(accessed/poslednji pristup: 06.06.2008).,OADS,/arxiv_data1/oa_pdf/88/6d/pharmpract-07-108.PMC4139748.pdf
"A hand search of the bibliographies  of retrieved articles, as well as a search of the  Research and Development projects funded  through the Pharmacy Guild of Australia  (http://beta.guild.org.au/re search/funded_projects.a sp) was also conducted.",OADS,/arxiv_data1/oa_pdf/12/29/pharmpract-07-001.PMC4139750.pdf
Thus it enables the pharmacist to identify potential non  adherence and propose to their customer to enroll  in one of the other professional pharmacy programs  such as the DAA or the PMP (Figure 1).26    Figure 1: Recommended actions on the basis of the  MedsIndex score  (http://www.medsindex.com.au/index.php/Content/what-is-medsindex.html)  CONCLUSIONS  Australian pharmacy schools are educating cohorts  of students who will have the skills to monitor and  support patient medication adherence in the context  of contemporary pharmacy practice.,Non-OADS,/arxiv_data1/oa_pdf/12/29/pharmpract-07-001.PMC4139750.pdf
URL:  http://www.guild.org.au/uploadedfiles/Research_and_Development_Grants_Program/Projects/2001-055_fr.pdf.,Non-OADS,/arxiv_data1/oa_pdf/12/29/pharmpract-07-001.PMC4139750.pdf
URL: http://www.guild.org.au/uploadedfiles/Research_and_Development_Grants_Program/Projects/2002-518_fr.pdf  (accessed 12 Dec. 08).,Non-OADS,/arxiv_data1/oa_pdf/12/29/pharmpract-07-001.PMC4139750.pdf
URL:  http://www.guild.org.au/uploadedfiles/Research_and_Development_Grants_Program/Projects/2002- 024%20Final%20version.pdf (accessed 30 January 2009)  12.,Non-OADS,/arxiv_data1/oa_pdf/12/29/pharmpract-07-001.PMC4139750.pdf
URL:  http://www.psa.org.au/site.php?id=1090 (accessed 15 July 2008).,OADS,/arxiv_data1/oa_pdf/12/29/pharmpract-07-001.PMC4139750.pdf
URL: http://www.guild.org.au/mmr/ (accessed  15 July 2008).,Non-OADS,/arxiv_data1/oa_pdf/12/29/pharmpract-07-001.PMC4139750.pdf
URL: https://www.medicareaustralia.gov.au/cgi- bin/broker.exe?_PROGRAM=sas.mb s_item_standard_report.sas&_SERVICE =default&DRILL=ag&_DEBUG=0&group= 900&VAR=services&STAT=count&RPT _FMT=by+state&PTYPE=finyear&START_DT=199807&END_DT=200812  (accessed 2 February 2009).,OADS,/arxiv_data1/oa_pdf/12/29/pharmpract-07-001.PMC4139750.pdf
Dose Administrati on Aids URL: http://www.guild.org.au/pps/content.asp?id=1425  (accessed 15 July 2008).,Non-OADS,/arxiv_data1/oa_pdf/12/29/pharmpract-07-001.PMC4139750.pdf
URL:  http://www.guild.org.au/uploadedfiles/Professional_Pharma cy_Services/PPS_Programs/Dose_Administration_Aids/2_o perations_manual.pdf (accessed 15 July 2008).,Non-OADS,/arxiv_data1/oa_pdf/12/29/pharmpract-07-001.PMC4139750.pdf
URL:  http://www.guild.org.au/uploadedfiles/Professional_Pharma cy_Services/PPS_Programs/Medication_Profiling/pmp_oper ations_manual_020408.pdf (accessed 15 July 2008).,Non-OADS,/arxiv_data1/oa_pdf/12/29/pharmpract-07-001.PMC4139750.pdf
URL : http://www.medsindex.com.au/index.php/Content/what-is- medsindex.html (accessed 15 July 08).,OADS,/arxiv_data1/oa_pdf/12/29/pharmpract-07-001.PMC4139750.pdf
"Available at:  http://data.unaids.org/pub/EPISlides/2007/071118_epi core2007_slides_en.pdf (accessed October 17, 2007).",OADS,/arxiv_data1/oa_pdf/bf/0a/pharmpract-07-011.PMC4139751.pdf
"Available at:  http://www.nytimes.com/2006/01/22/magazine/22wwln_essay.html (accessed July 2, 2008).",Non-OADS,/arxiv_data1/oa_pdf/bf/0a/pharmpract-07-011.PMC4139751.pdf
Standards for quality of pharmacy services approved by the FIP Congress in September 1997.  http://www.fip.org/www2/uploads/database_file.php?i d=261&table_id= (Assessed: 23 January 2008)  30.,Non-OADS,/arxiv_data1/oa_pdf/b1/bc/pharmpract-07-019.PMC4139752.pdf
"Available at URL: http://www.merck.com (accessed June 6, 2005).",Non-OADS,/arxiv_data1/oa_pdf/03/c0/pharmpract-07-029.PMC4139753.pdf
"Available at   URL: http://www.utoronto.ca/kids/aboveruse.htm (accessed on June 6, 2005).",Non-OADS,/arxiv_data1/oa_pdf/03/c0/pharmpract-07-029.PMC4139753.pdf
The  video was posted on the OU College of Pharmacy  website on the Office of  Experiential Education  home page  (http://pharmacy.ouhsc.edu/academic/experiential.a sp).,Non-OADS,/arxiv_data1/oa_pdf/0a/c9/pharmpract-07-047.PMC4139756.pdf
"Available at:  http://www.aacp.org/Docs/MainNavigation/Instituti onalData/6676_2005-03.pdf (accessed February 26, 2007).",Non-OADS,/arxiv_data1/oa_pdf/0a/c9/pharmpract-07-047.PMC4139756.pdf
"Available at:  http://www.aacp.org/site/page.asp?TRACKID=&VID= 1&CID=807&DID=5296 (accessed February 26, 2007).",OADS,/arxiv_data1/oa_pdf/0a/c9/pharmpract-07-047.PMC4139756.pdf
"Achieving Preceptor Excellenc e. Available at: http://www.cop.ufl.edu/APEX/ (accessed February 3, 2008).",Non-OADS,/arxiv_data1/oa_pdf/0a/c9/pharmpract-07-047.PMC4139756.pdf
"Ministry of Health, Labor and Welfare, The survey of medical care activity in public health insurance in 2006,  http://www.mhlw.go.jp/toukei/saikin/hw/sinry o/tyosa06/2-4.html (accessed 30-Oct-2008).",Non-OADS,/arxiv_data1/oa_pdf/8c/aa/pharmpract-07-059.PMC4139758.pdf
"Special Committee on health care system for the latter-stage elderly of Social Security Council, Medical fee scheme of  health care system for the latter-stage elderly, Oct.,  10 2007, http://www.mhlw.go.jp/shingi/2007/10/dl/s1010-7a.pdf  (accessed 30-Oct-2008).",Non-OADS,/arxiv_data1/oa_pdf/8c/aa/pharmpract-07-059.PMC4139758.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Food & Nutrition Research 2014, 58: 24604 - http://dx.doi.org/10.3402/fnr.v58.24604 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/88/89/FNR-58-24604.PMC4139929.pdf
"2 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24604 - http://dx.doi.org/10.3402/fnr.v58.24604",Non-OADS,/arxiv_data1/oa_pdf/88/89/FNR-58-24604.PMC4139929.pdf
"Macronutrient and fatty acid composition of A04 diet and wheat aleurone A04 diet (SAFE) Wheat aleurone g/100 g Proteins 16.1 12.6 T otal carbohydrates 59.9 61.8 Lipids 3.1 8.7 Fatty acids mg/100 g lipidSaturated fatty acids 620 955C18:1n-9 400 1,211C18:2n-6 1,310 3,240C18:3n-3 110 326C20:4n-6 0.0 0.6C20:5n-3(eicosapentaenoic acid) 20 12 C22:5n-3 10 11 C22:6n-3(docosahexaenoic acid) 30 1.2Wheat aleurone and VLC n-3 fatty acids Citation: Food & Nutrition Research 2014, 58: 24604 - http://dx.doi.org/10.3402/fnr.v58.24604 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/88/89/FNR-58-24604.PMC4139929.pdf
"4 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24604 - http://dx.doi.org/10.3402/fnr.v58.24604",Non-OADS,/arxiv_data1/oa_pdf/88/89/FNR-58-24604.PMC4139929.pdf
"WA /C30wheat aleurone pellets, CP /C30control pellets.Wheat aleurone and VLC n-3 fatty acids Citation: Food & Nutrition Research 2014, 58: 24604 - http://dx.doi.org/10.3402/fnr.v58.24604 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/88/89/FNR-58-24604.PMC4139929.pdf
"6 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 24604 - http://dx.doi.org/10.3402/fnr.v58.24604",Non-OADS,/arxiv_data1/oa_pdf/88/89/FNR-58-24604.PMC4139929.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial u se, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"Although the JP2 clone-associatedDorte Haubek and Anders Johansson 2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980",OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"Non-JP2Highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"(34) 500 Ghana 44 Ghanaian (44)Dorte Haubek and Anders Johansson 4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"eAaisolates were obtained from patients with Down syndrome with or without periodontitis.Highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"Since theclone is most likely acquired by vertical transmissionfrom parent to child, transmission of JP2 clone strainsprobably occurs even before the ages mentioned above.Dorte Haubek and Anders Johansson 6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"Although mapping of the geographicoccurrence of the JP2 clone of A. actinomycetemcomitansHighly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"(B) Dots illustrate the countries from where JP2 clone-positive patients have been identiﬁed (as indicated in Table 1).Dorte Haubek and Anders Johansson 8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"Therefore, the real-time PCR method has not yet con-tributed with results or conclusions on quantitative aspects of the presence of JP2 and non-JP2 genotypes of A. actinomycetemcomitans and the initiation and devel- opment of periodontal attachment loss among the young.Highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"However, the serum-mediated release of the toxin (144, 145), as well as its highly systemic immunogenic response (146), indicateDorte Haubek and Anders Johansson 10 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"It has also been shown that the human naturalkiller (NK) cells are affected in a similar way by LtxA asthe T-cells are, while the effects of LtxA on human B-cells or plasma cells have not been specifically addressed (165).Highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"A secondary stimulus is needed to induce activation and release of the accumu-lated precursors of IL-1 band IL-18 in the primedDorte Haubek and Anders Johansson 12 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"177).Highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"177).Dorte Haubek and Anders Johansson 14 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980",OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"These provide an excellent plat- form for more studies on the details of the patho-genic mechanisms of A. actinomycetemcomitans in the future.Highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980 15 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"MolecularDorte Haubek and Anders Johansson 16 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980",OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"Periodontol 2000 2005; 39: 91 /C1117.Highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980 17 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"Aggressive periodontitis in a 16-year-old Ghanaian adolescent, theoriginal source of Actinobacillus actinomycetemcomitans strainDorte Haubek and Anders Johansson 18 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemco-Highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980 19 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"Leukotoxin (Leukothera †) targets active leukocyte function antigen-1 (LFA-1) protein and triggers aDorte Haubek and Anders Johansson 20 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"APMIS 2008; 116: 499 /C1506.Highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980 21 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"Kwamin F , Gref R, Haubek D, Johansson A. Interactions of extracts from selected chewing stick sources with Aggregatibacter actinomycetemcomitans .B M CR e sN o t e s2 0 1 2 ;5 :2 0 3 .Dorte Haubek and Anders Johansson 22 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2014, 6: 23980 - http://dx.doi.org/10.3402/jom.v6.23980",OADS,/arxiv_data1/oa_pdf/23/ab/JOM-6-23980.PMC4139931.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2014, 3: 24215 - http://dx.doi.org/10.3402/jev.v3.24215 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 24215 - http://dx.doi.org/10.3402/jev.v3.24215",OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
"Breast milkEV from human breast milk Citation: Journal of Extracellular Vesicles 2014, 3: 24215 - http://dx.doi.org/10.3402/jev.v3.24215 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 24215 - http://dx.doi.org/10.3402/jev.v3.24215",OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
"Indicated are the quantiﬁed western blot signals (mean values of 2 indepen- dent experiments in 2 different donors) normalized to the values detected in the 1.13 /C11.18 g/ml fractions of the PBS/BSA control (set to 100%).EV from human breast milk Citation: Journal of Extracellular Vesicles 2014, 3: 24215 - http://dx.doi.org/10.3402/jev.v3.24215 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 24215 - http://dx.doi.org/10.3402/jev.v3.24215",OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
"(b, c) The protein content of individual density fractions was assessed by Coomassie blue staining (representative of 2 different donors) (b) and by western blotting for HLA class II, hCD63, hCD9, b-casein, and lactoferrin (representative of 3 different donors) (c).EV from human breast milk Citation: Journal of Extracellular Vesicles 2014, 3: 24215 - http://dx.doi.org/10.3402/jev.v3.24215 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 24215 - http://dx.doi.org/10.3402/jev.v3.24215",OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
"*pB0.05; **p B0.01.EV from human breast milk Citation: Journal of Extracellular Vesicles 2014, 3: 24215 - http://dx.doi.org/10.3402/jev.v3.24215 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 24215 - http://dx.doi.org/10.3402/jev.v3.24215",OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
"Human saliva, plasma and breast milkEV from human breast milk Citation: Journal of Extracellular Vesicles 2014, 3: 24215 - http://dx.doi.org/10.3402/jev.v3.24215 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
"J Extracell Vesicles 2013;2:20360, doi: http://dx.doi.org/10.3402/jev.v2i0.20360 17.",OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
"J Extracell Vesicles 2012;1:18364, doi: http://dx.doi.org/10.3402/jev.v1i0.18364 42.",OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
"J Extracell Vesicles.2012;1:18397, doi: http://dx.doi.org/10.3402/jev.v1i0.18397 46.",OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 24215 - http://dx.doi.org/10.3402/jev.v3.24215",OADS,/arxiv_data1/oa_pdf/7f/8a/JEV-3-24215.PMC4139932.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a2/0f/srep06143.PMC4139941.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6143 | DOI: 10.1038/srep06143 9",Non-OADS,/arxiv_data1/oa_pdf/a2/0f/srep06143.PMC4139941.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/66/35/srep06155.PMC4139942.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6155 | DOI: 10.1038/srep06155 5",Non-OADS,/arxiv_data1/oa_pdf/66/35/srep06155.PMC4139942.pdf
Preprint at http://arxiv.org/abs/1308.2634 (2013).,Non-OADS,/arxiv_data1/oa_pdf/c3/6a/srep06153.PMC4139943.pdf
Preprint at http://arxiv.org/abs/1401.0373 (2014).,Non-OADS,/arxiv_data1/oa_pdf/c3/6a/srep06153.PMC4139943.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c3/6a/srep06153.PMC4139943.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6153 | DOI: 10.1038/srep06153 7",Non-OADS,/arxiv_data1/oa_pdf/c3/6a/srep06153.PMC4139943.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/51/4c/srep06150.PMC4139944.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6142 | DOI: 10.1038/srep06142 5",Non-OADS,/arxiv_data1/oa_pdf/41/5e/srep06142.PMC4139945.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6154 | DOI: 10.1038/srep06154 13",Non-OADS,/arxiv_data1/oa_pdf/d2/4b/srep06154.PMC4139947.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9f/b8/srep06141.PMC4139948.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6141 | DOI: 10.1038/srep06141 7",Non-OADS,/arxiv_data1/oa_pdf/9f/b8/srep06141.PMC4139948.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e5/ff/srep06147.PMC4139949.pdf
"Subsequently, they were submitted to the GenBank database of the National Center for Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov) for alignment employing the Basic Local Alignment Search Tool (BLASTN) algorithm of nucleotide in the 16S rRNA sequences (Bacteria and Archaea) database to determine their phylogenetic affiliations.",OADS,/arxiv_data1/oa_pdf/a6/2f/srep06151.PMC4139950.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a6/2f/srep06151.PMC4139950.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6151 | DOI: 10.1038/srep06151 10",Non-OADS,/arxiv_data1/oa_pdf/a6/2f/srep06151.PMC4139950.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/39/55/srep06148.PMC4139951.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/47/f2/srep06152.PMC4139953.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6152 | DOI: 10.1038/srep06152 11",Non-OADS,/arxiv_data1/oa_pdf/47/f2/srep06152.PMC4139953.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c5/62/srep06140.PMC4139954.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6140 | DOI: 10.1038/srep06140 8",Non-OADS,/arxiv_data1/oa_pdf/c5/62/srep06140.PMC4139954.pdf
"Discovery Institute, (2008) (Date ofaccess:08/04/2014, Available: http://www.discovery.org/a/4428).",OADS,/arxiv_data1/oa_pdf/3c/b9/srep06156.PMC4139967.pdf
"White Paper, Cisco Systems (2011) (Date of access:08/04/2014, Available: http://www.cisco.com/en/US/solutions/collateral/ns341/ns525/ns537/ns705/ns827/white_paper_c11- 481360_ns827_Networking_Solutions_White_Paper.html).",OADS,/arxiv_data1/oa_pdf/3c/b9/srep06156.PMC4139967.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3c/b9/srep06156.PMC4139967.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK27035/ [Last accessed on 2008 Jul 14].,Non-OADS,/arxiv_data1/oa_pdf/7f/1e/ABR-3-146.PMC4139985.pdf
Available from: http://www.who.int/health-servicesdelivery/human/workforce/papers/HR.pdf [Last accessed on 2013 Dec 4].,OADS,/arxiv_data1/oa_pdf/23/5a/JFMPC-3-102.PMC4139987.pdf
Available from: http://www.nohp.org.in/aboutus/NOHP.aspx.,Non-OADS,/arxiv_data1/oa_pdf/73/ee/JFMPC-3-107.PMC4139988.pdf
Available from: http://www.ijdr.in/text.asp?2009/20/1/129/49054.,Non-OADS,/arxiv_data1/oa_pdf/73/ee/JFMPC-3-107.PMC4139988.pdf
Available from: http://www.planningcommission.nic.in/aboutus/committee/wrkgrp11/wg11_comble.pdf.,Non-OADS,/arxiv_data1/oa_pdf/73/ee/JFMPC-3-107.PMC4139988.pdf
Available from: http://www.who.int/chp/steps/riskfactor/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/77/0a/JFMPC-3-112.PMC4139989.pdf
Available from: http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/77/0a/JFMPC-3-112.PMC4139989.pdf
Available from: http://www.care.,Non-OADS,/arxiv_data1/oa_pdf/77/0a/JFMPC-3-112.PMC4139989.pdf
Available from: http://www.who.int/ nmh/events/2009/meeting_report_20090822.pdf [Last accessed on 2013 Jul 9].,Non-OADS,/arxiv_data1/oa_pdf/77/0a/JFMPC-3-112.PMC4139989.pdf
Available from: http://www.who.int/dietphysical activity/physical-activity- recommendations-18-64years.pdf [Last accessed on 2013  Jul 9].,OADS,/arxiv_data1/oa_pdf/77/0a/JFMPC-3-112.PMC4139989.pdf
Available from:http://www.vaccineschedule.in/typhoidvaccines.aspx</loc.,Non-OADS,/arxiv_data1/oa_pdf/96/1a/JFMPC-3-132.PMC4139993.pdf
Available  from: http://www.chestofbooks.com/health/nutrition/Dietetics-5/Group-II-Choice-Of-Foods-For-Typhoid-Fever.html.,Non-OADS,/arxiv_data1/oa_pdf/96/1a/JFMPC-3-132.PMC4139993.pdf
Available from: http://health.cg.gov.in/ehealth/studyreports/Why%20Some%20Doctors%20Serve%20in%20Rural%20Areas.pdf [Last cited on 2011 May 10].,Non-OADS,/arxiv_data1/oa_pdf/6f/a1/JFMPC-3-141.PMC4139995.pdf
Available from: http://www.mohfw.nic.in/NRHM/Documents/NRHM%20Mission%20Document.pdf [Last accessed on 2011 Nov 10].,OADS,/arxiv_data1/oa_pdf/6f/a1/JFMPC-3-141.PMC4139995.pdf
Available from: http://www.mohfw.nic.in/NRHM.htm [Last accessed on 2011 Nov 15]  21.,Non-OADS,/arxiv_data1/oa_pdf/6f/a1/JFMPC-3-141.PMC4139995.pdf
Available from: http://apps.who.int/gho/data/node.country.country-SAU.,OADS,/arxiv_data1/oa_pdf/30/ba/JFMPC-3-146.PMC4139996.pdf
Available from: http://www.who.int/mental_health/policy/services/SaudiArabia.pdf.,Non-OADS,/arxiv_data1/oa_pdf/30/ba/JFMPC-3-146.PMC4139996.pdf
Available from: http://www.choosingwisely.org/.,Non-OADS,/arxiv_data1/oa_pdf/67/1a/JFMPC-3-171.PMC4140005.pdf
Available  from: http://www.choosingwisely.org/.,Non-OADS,/arxiv_data1/oa_pdf/99/3c/JFMPC-3-172.PMC4140006.pdf
Available from: http://www.planningcommission.nic.in/reports/genrep/rep_uhc0812.pdf.,Non-OADS,/arxiv_data1/oa_pdf/da/b3/JFMPC-3-91.PMC4140007.pdf
Available from: http://www.daily.bhaskar.com/article/MAH-MUM-maharashtra-news-maharashtra-government-says-homeopathic-doctors-can-provide-all-4494820-NOR.html.,Non-OADS,/arxiv_data1/oa_pdf/da/b3/JFMPC-3-91.PMC4140007.pdf
